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Electromagnetic Hypersensitivity (EHS), more formally known as Idiopathic 
Environmental Intolerance attributed to Electromagnetic Fields (IEI-EMF), is a 
controversial condition characterised by the experience of a broad range of non-specific 
symptoms which a person attributes to the electromagnetic fields (EMF) emitted by 
everyday electronic and wireless technologies. In contrast to growing anecdotal reports 
of sensitivity to EMF, much of the existing literature has not found evidence that 
exposure to EMF can result in the symptoms reported by IEI-EMF sufferers. Instead, 
the condition is thought to be the result of a nocebo effect, where conscious or 
subconscious symptom expectation leads to the development and detection of 
symptoms. Yet, despite decades of research, IEI-EMF sufferers and a minority of 
scientists argue that the symptoms are caused by exposure to EMF, via some as-yet 
unrecognised bioelectromagnetic mechanism. 
In an effort to resolve the aetiological debate, this thesis aimed to clarify whether 
toxicogenic or psychogenic processes can explain the symptoms reported by IEI-EMF 
sufferers. Specifically, a number of methodological issues were addressed to more 
clearly determine whether individuals can be sensitive to EMF exposure, or whether 
psychogenic processes play a role in the presentation of symptoms attributed to EMF 
exposure. 
First, as a means of establishing whether radiofrequency EMF (RF-EMF) exposure 
below the established safety guidelines could elicit adverse effects in humans and in an 
attempt to determine the most sensitive objective endpoints to test IEI-EMF 
participants, Study 1 investigated whether exposure to RF-EMF influences human 




exposure to RF-EMF can improve reaction time on a working memory task, given that 
methodological improvements employed in this study have not yet been replicated, and 
given that the effect was not found to be dose-dependent and that an improvement in 
performance does not reflect an adverse health effect, Study 1 did not provide 
convincing evidence that exposure to RF-EMF can adversely affect cognitive 
functioning. Furthermore, the study did not identify any sensitive cognitive performance 
measures with which to test IEI-EMF sufferers. This line of research was thus 
discontinued. 
Study 2 aimed to determine whether the symptoms reported by IEI-EMF sufferers can 
be explained by toxicogenic or psychogenic processes, and incorporated several 
methodological improvements to overcome the limitations of previous research. The 
study was designed as a series of individual case studies to test whether exposure to RF-
EMF results in an increase in IEI-EMF participants’ self-nominated symptoms 
compared to sham, and , to determine whether IEI-EMF individuals could accurately 
detect the presence of RF-EMF emissions under double-blind conditions. Despite 
accounting for a number of potential limitations, the results of the case studies failed to 
demonstrate that the symptomatic response of self-reported IEI-EMF sufferers is 
affected by RF-EMF exposure, nor that IEI-EMF sufferers can detect the presence of 
RF-EMF emissions at greater than chance levels. While all participants displayed an 
increased symptom severity and were confident that they could detect the presence of 
RF-EMF in the open-label RF-ON but not RF-OFF trial, no significant differences in 
symptom severity or exposure detection were found between the double-blind RF-ON 
and RF-OFF (sham) conditions. Notably, a significant relationship between a 




condition) and their symptomatic response was observed, giving a strong indication the 
symptoms experienced were due to a nocebo response, and therefore, that IEI-EMF can 
be explained by psychogenic processes. 
Study 3 extended upon Study 2 by investigating whether a nocebo response is specific 
only to IEI-EMF sufferers, and by examining the potential role of psychological 
processes in the presentation of symptoms attributed to EMF exposure. Healthy 
participants were randomly assigned to watch either an alarmist video emphasising 
‘adverse effects of EMF exposure’ or a control video completely unrelated to EMF and 
health, before completing a series of open-label and double-blind provocation trials. 
Consistent with Study 2, results showed that healthy participants reported higher 
symptoms in the open-label RF-ON compared to the RF-OFF trial. However, in the 
subsequent double-blind trials, no difference in either belief of exposure or symptoms 
was found between the RF-ON and sham conditions. Belief of exposure was also 
positively associated with higher symptom scores in the double-blind trials, further 
indicating that a nocebo effect, rather than EMF exposure itself, was responsible for the 
increase in symptoms. Additionally, participants who viewed the alarmist video 
reported higher symptom scores in the open-label trials, as well as a greater increase in 
state anxiety and risk perception from baseline, than those who viewed the control 
video. This indicates that viewing sensationalist media reports about perceived 
environmental hazards raises concerns and negative beliefs about EMF exposure, and 
may exacerbate a nocebo response, suggesting that the degree to which people 
experience symptoms that they believe are associated with EMF exposure may be 




Taken together, the findings from this thesis do not support the notion that toxicogenic 
processes can explain the symptoms attributed to EMF exposure. Instead the studies 
presented provide strong support for the view that psychological factors play an 
important role in triggering, maintaining, or exacerbating symptoms in response to 
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1.  CHAPTER 1: GENERAL INTRODUCTION 
The research presented in this doctoral thesis was designed to investigate the 
determinants of Idiopathic Environmental Intolerance attributed to Electromagnetic 
Fields (IEI-EMF), a controversial condition more commonly referred to as 
Electromagnetic Hypersensitivity (EHS). While continuing technological advances have 
generally benefited greater society, the unprecedented rise in the number and diversity 
of electromagnetic field (EMF) sources has raised public concerns about potential 
adverse health risks posed by our increasing exposure to EMF. Amongst these concerns 
are the reports of a proportion of the population who claim to experience a variety of 
health problems which they attribute to exposure to EMF. As the associated symptoms 
are debilitating for many, it is crucial to understand the determinants of this condition. 
Two alternate theories have been proposed to explain the origin of the symptoms 
reported by individuals who suffer from IEI-EMF; namely the toxicogenic theory and 
the psychogenic theory. While much of the extant literature indicates that the reported 
symptoms are of a psychogenic origin, a number of methodological issues need to be 
overcome before this can be conclusively determined, and much remains to be clarified. 
In an effort to resolve the aetiological debate, the empirical studies presented in this 
thesis specifically sought to address a number of methodological issues to more clearly 
determine whether individuals can be sensitive to EMF exposure, and to examine the 
potential role of psychogenic processes in the presentation of symptoms attributed to 
EMF exposure. The following chapter outlines the general background and rationale for 





1.1  Background 
The use of wireless technology has rapidly increased over the past two decades with the 
continuing development of mobile phone, laptop, tablet and smart devices. Globally, the 
United Nations estimates that there are approximately 7 billion active mobile phone 
subscriptions (International Telecommunications Union, 2017), a figure almost 
equivalent to the total human population. In Australia, one of the country’s largest 
telecommunications companies has introduced over 2 million public wireless fidelity 
(Wi-Fi) hotspots since 2015 to cope with the increasing demand for access to high 
speed wireless internet (Telstra, 2014), while state utility companies across the nation 
are beginning to introduce smart metres, which communicate wirelessly, to track 
household electricity use (Energy Australia, 2014). By 2020, the roll out of 5G 
technology will further drive society globally into the ‘internet of things’, where various 
numbers of smart devices will communicate wirelessly with each other in an effort to 
improve the lives of the people who use them. There is probably no other technology 
that has been so quickly and widely adopted by the general public in recent times 
(Stewart, 2008). 
Yet, despite the benefits associated with the introduction and widespread use of wireless 
technologies, concerns have been raised about whether there may be adverse health 
effects associated with our increasing exposure to the non-ionising EMF utilised by 
these devices. These concerns have been partially driven by reports from a proportion of 
the population who claim to have detected a clear association between their experience 
of distressing and sometimes debilitating symptoms and their exposure to the EMF 




1). These individuals suffer from a condition commonly described as Electromagnetic 
Hypersensitivity (EHS).  
Vignette 1:  
Steve (aged 45 years), is an IT professional who has been using computers his 
entire adult life. He has always considered himself an early adopter of new 
technologies. In 2001, after purchasing one of the most powerful Wi-Fi routers 
at the time, Steve began to experience symptoms including pressure in the chest, 
pressure in the head, mood changes, and tingling sensations in the hands and 
face within minutes using the Wi-Fi router. After turning off the Wi-Fi router, he 
experienced a headache that persisted for several hours. Steve soon believed that 
there was a consistent pattern between the symptoms that he was experiencing 
and the use of his Wi-Fi router. With the subsequent rollout and advancement of 
other wireless technologies including mobile phones, smart metres, digital 
cordless telephones and inflight Wi-Fi, Steve’s health worsened to a point where 
he began to experience sleeping difficulties, constant headaches and extreme 
lethargy. These symptoms then resulted in a complete loss of motivation to do 
activities with his family and forced him to only use the rear parts of his home, 
which he shielded with metallic paint and “RF blocking” curtains. He can no 
longer drive through suburbs where smart metres have been installed without 
developing a serious headache that can last for several days. Steve is deeply 
concerned about the lack of support, care and understanding he has experienced 
from medical professionals, power utilities and various government departments 





The aetiology of this condition, however, is extremely controversial. While some 
researchers and many of those who suffer from the condition believe that it is caused by 
exposure to EMF, to date, there has been insufficient scientific evidence to support this 
claim. Instead, much of the evidence suggests that that the condition is likely the result 
of a nocebo response (Röösli, Frei, Mohler, & Hug, 2010; Rubin, Das Munshi, & 
Wessely, 2005; Rubin, Nieto-Hernandez, & Wessely, 2010), where conscious or 
subconscious symptom expectation following a perceived exposure to EMF leads to the 
formation or detection of symptoms. Due to the lack of evidence for a relationship 
between the reported symptoms and exposure to EMF, the World Health Organisation 
(WHO) proposed the term ‘Idiopathic Environmental Intolerance attributed to 
Electromagnetic Fields’ (IEI-EMF) to be used in place of ‘Electromagnetic 
Hypersensitivity’ (EHS), in order to avoid implying a causal role of EMF in producing 
the reported symptoms (World Health Organisation, 2004)1.  
Idiopathic Environmental Intolerance (IEI) is an umbrella term used to describe a group 
of health conditions that are characterised by the experience of a wide range of somatic, 
non-specific symptoms which are claimed to arise in response to environmental 
triggers, but for which there is no established evidence of a relationship between the 
claimed environmental triggers and adverse symptoms (Van den Bergh, Brown, 
Petersen, & Witthöft, 2017). As well as being used to describe the symptoms which 
people attribute to EMF, the IEI term has also been used to describe a number of other 
conditions such as Multiple Chemical Sensitivity (MCS), which refers to the attribution 
of symptoms to a wide range of everyday chemical sources (which may include 
                                                     





cleaning products, air pollution and pesticides); and Infrasound Hypersensitivity (IHS), 
more commonly known as Wind Turbine Syndrome, which refers to the attribution of 
symptoms to the low frequency noise emitted by wind turbines. The aetiologies of the 
IEI conditions are controversial for a number of reasons. First, there is often no 
established relationship between the environmental exposure claimed to trigger 
symptoms and organ pathology or dysfunction. Second, the reported symptoms are 
extremely heterogeneous, and are often alleged to be triggered by environmental 
exposures at strengths well below the thresholds currently known to cause adverse 
health effects. In addition to this, there is generally no evidence to suggest that the 
symptoms claimed by IEI sufferers are associated with the claimed exposures. For 
instance, MCS and IEI-EMF sufferers who participate in well-designed laboratory 
studies which use double-blind protocols and utilise the particular environmental 
exposures purported to be responsible for symptoms generally fail to have their 
symptom claims verified in active compared to sham exposures, and instead 
behavioural and psychological processes have been consistently found to play a role in 
the presentation of symptoms (Das-Munshi, Rubin, & Wessely, 2006; Rubin et al., 
2005; Rubin et al., 2010). Likewise, there is no evidence of a direct causal link between 
living in close proximity to wind turbines, the noise they emit and the physiological 
health effects claimed to be attributable to wind turbines by IHS sufferers (Knopper & 
Ollson, 2011). Finally, there is a large symptom overlap between IEI’s and other 
somatoform disorders and functional syndromes such as chronic fatigue syndrome and 
fibromyalgia (Van den Bergh et al., 2017).  
Like the other IEI conditions, the discrepancy between the scientific evidence and the 




aetiology of IEI-EMF. On one side, advocates of the toxicogenic explanation argue that 
the adverse symptoms reported by IEI-EMF sufferers are the result of an intolerance or 
susceptibility to exposure to low levels of EMF, which affects the human body via some 
as-yet unrecognised toxicogenic or ‘bioelectromagnetic’ mechanism (Rubin et al., 2010; 
Staudenmayer, Binkley, Leznoff, & Phillips, 2003a). Alternatively, proponents of a 
psychogenic explanation contend that the condition can be explained by an individual’s 
overvalued belief of toxicity, a belief which is shaped by a range of psychological, 
psychosocial and psychophysiological processes (Staudenmayer, Binkley, Leznoff, & 
Phillips, 2003b) and which ultimately culminates in the presentation of adverse 
symptoms via a nocebo response.  
Given the debilitating nature of IEI-EMF (as described in Vignette 1), resolving the 
aetiological debate is extremely important, not least because the two opposing theories 
have very different implications in terms of identifying and developing the most 
appropriate treatments and support for those who experience the condition (Rubin, Das 
Munshi, & Wessely, 2006; Rubin et al., 2010). For instance, if EMF exposure is indeed 
responsible for the development of these symptoms, then exposure reduction and 
avoidance may be the most suitable strategy to alleviate symptoms. Conversely, if the 
symptoms are the result of a nocebo effect, then a psychologically complex scenario 
needs to be dealt with. Investigating the determinants of this condition forms the focus 
of this thesis.  
1.2  Electromagnetic Fields and Health 
Electromagnetic fields (EMF) are waves of energy which radiate through space. These 
waves are generated by both natural and man-made sources, and are comprised of two 




2017). E-fields are measured in volts per-metre (V/m) and are present whenever 
positive or negative electrical charges exert force on other charged particles in the field. 
E-fields are strongest closer to the device (for e.g. a mobile phone) and diminish rapidly 
with greater distance from the source (Wood & Roy, 2017; World Health Organisation, 
2018). H-fields are measured in amperes per metre (A/m) and are produced by the 
physical movement of electrical charges. Like E-fields, H-fields are strongest closer to 
the source and diminish with greater distance from the source (Wood & Roy, 2017; 
World Health Organisation, 2018). EMFs are defined by the frequency or corresponding 
wavelength of the electromagnetic wave. Frequency is used to describe the number of 
oscillations or cycles per second (typically measured in Hertz (Hz)), while wavelength 
is used to describe the distance between one peak (or trough) of the electromagnetic 
wave and the next peak (or trough) (World Health Organisation, 2018). Frequency and 
wavelength have an inverse relationship, the higher the frequency, the shorter the 
wavelength.  
EMF can be classified into different ranges based on frequency and/or wavelength. 
When arranged on a continuum they form what is known as the electromagnetic 
spectrum. Based on frequency, the spectrum is divided into two distinct categories; 
ionising and non-ionising radiation. Figure 1.1 illustrates the distinction between 
ionising and non-ionising EMF and delineates the frequency bands typically used to 





Ionising radiation is at the high frequency (and thus high-energy) end of the spectrum 
and includes X-rays and gamma rays. Ionising radiation carries enough energy to free 
electrons from atoms or molecules, thereby creating free radicals, which are highly 
reactive. These free radicals can effectively break chemical bonds and damage 
biological tissue. While the destructive and detrimental effects of ionising radiation are 
well-known (for example when used in atomic weapons or during and following a 
nuclear reactor meltdown), ionising radiation is also used in a beneficial way in 
medicine, for example in radiography and cancer treatments. Non-ionising radiation, on 
the other hand, is at the lower-energy end of the spectrum and refers to the 
electromagnetic radiation that does not carry sufficient energy to remove electrons from 
atoms or molecules. Extremely Low Frequency (ELF) radiation, Radiofrequency (RF) 
radiation, infrared radiation, visible light, and Ultra Violet (UV) radiation are all forms 
of non-ionising EMF. Generally, electronic and wireless technologies utilise EMF in the 
ELF (from 3 to 30 Hz) and RF (from 3 kHz to 300 GHz) bands of the non-ionising 







radiation domain (ARPANSA, 2012). A number of biological and health effects from 
exposures to high intensities of non-ionising EMF have been well documented. These 
effects generally relate to the localised heating or stimulation of excitable tissue that is 
associated with the amount of energy absorbed by the body (Repacholi, 1998). The rate 
and distribution of energy absorption in the body depends strongly on the frequency, 
strength and orientation of the incident EMF2 as well as the body’s size and its electrical 
properties (Health Canada, 2015).  
The absorption of RF-EMF by the human body is commonly described in terms of the 
specific absorption rate (SAR), which is a measure of the rate of energy deposition per 
unit mass of body tissue and is usually expressed in units of watts per kilogram (W/kg). 
It is important to note that the high exposure levels known to adversely affect human 
health via thermal mechanisms do not exist in daily life, as the technologies which 
utilise RF-EMF are heavily regulated by governments and health agencies (for example 
ARPANSA, 2002) using internationally recognised safety guidelines (for example 
ICNIRP, 1998). For instance, the ICNIRP (1998) RF-EMF guidelines are based on SAR 
limits at many orders of magnitude lower than the thresholds known to cause 
temperature increases that would affect human health. For the general public, these 
guidelines recommend limiting the SAR to 2 W/kg; while for people undergoing 
occupational exposure, the guidelines recommend a limit of 10 W/kg (averaged over 10 
grams of tissue) (ICNIRP, 1998). Likewise, internationally recognised safety guidelines 
have been developed to protect humans against the potential adverse effects of ELF-
EMF exposures (ICNIRP, 2010). Exposure to high intensity ELF-EMF may cause well-
defined biological responses, including perception and annoyance, alterations in some 
                                                     




aspects of brain and nervous system function, and the induction of retinal phosphenes 
(the perception of faint flickering light in the absence of visual input). The physical 
quantity used to specify the exposure limits for ELF-EMF is the internal electric field 
strength (Ei), as it is the electric field that affects nerve cells and other electrically 
sensitive cells. However, as this value is often difficult to derive, reference levels based 
on measurements (or computations) of electric field strength, magnetic field strength, 
magnetic flux density and currents flowing through the limbs can be used to ensure 
compliance with the relevant exposure limit (ICNIRP, 2010). With the exception of 
some medical exposures to patients and some specialised occupational exposures, 
exposure to the high levels of ELF-EMF that are known to cause adverse health effects 
in humans are extremely rare, and are unlikely to occur in daily life. 
Despite a number of authoritative reviews of the scientific literature generally 
concluding that there are no established health risks associated with exposure to EMF 
within the established guidelines, nor any established mechanism by which this could 
occur (Health Canada, 2015; Health Council of the Netherlands, 2009; SCENIHR 
(Scientific Committee on Emerging and Newly Identified Health Risks), 2009; World 
Health Organisation, 2014), the rapid development and increasing use of wireless 
technologies has generated considerable public concern about potential adverse health 
effects of exposure to EMF below the established exposure guidelines (World Health 
Organisation, 2018).  
Evidence that EMF exposure below the established guidelines can have biological or 
physiological effects is often used by IEI-EMF sufferers and advocates as arguments to 
suggest that EMF exposure can adversely affect health (for example. BioInitiative 




between biological/physiological effects and health effects. Biological/physiological 
effects are measurable responses to a stimulus or to a change in the environment, but 
they are not necessarily harmful for human health (World Health Organisation, 2018). 
These often occur in daily life, for example when eating food, playing sport or listening 
to music. Conversely, an adverse health effect is something which results in a detectable 
impairment in the health of the exposed individual (World Health Organisation, 2018). 
One of the most consistently reported effects of RF-EMF exposure, similar to that 
emitted by mobile phones, are alterations in the brain’s electrical activity, specifically in 
the spontaneous resting alpha (8 – 12 Hz) (Croft et al., 2008; Croft et al., 2010; Curcio 
et al., 2005; Leung et al., 2011) and the sleep spindle frequency range (approximately 
11 – 15 Hz) (Huber et al., 2000; Huber et al., 2002; Loughran et al., 2005; Regel et al., 
2007; Schmid et al., 2012) of the electroencephalograph (EEG). These effects have been 
found to occur in a dose-dependent manner. Although dose dependency is a 
fundamental principle of toxicology, and refers to the change in effect caused by 
differing levels of exposure (Staudenmayer et al., 2003a), the change in EEG as a result 
of exposure to RF-EMF may not necessarily reflect an adverse health effect.  
While the EEG is closely related to cognitive and mental processes and states 
(Andreassi, 2007), studies investigating the effect of RF-EMF on gross measures of 
cognitive performance, such as response times and accuracy, have produced 
contradictory, but mostly null results. For instance, one meta analyses reported that 
human attention and working memory is affected by exposure to EMF (Barth et al., 
2008), while other meta analyses have found no influence of exposure on gross 
measures of performance (Barth, Ponocny, Gnambs, & Winker, 2012; Valentini, 




be due to a number of methodological issues, including variation in methods between 
research groups (making it difficult to compare or verify previous results), poor 
exposure protocols and experimental designs, inadequate sample sizes and a lack of 
reliable cognitive performance measures (Regel & Achermann, 2011). In addition, 
individual differences in cognitive performance have not been adequately accounted for 
in previous studies, nor has the potential influence of thermal variability, which may be 
particularly important given that exposure to RF-EMF imparts a thermal load on the 
body (Adair & Black, 2003). Given these issues, the associated functional 
consequence(s) of the change in EEG, if any, remains to be clearly determined, and as 
such, there is some uncertainty as to whether exposure to RF-EMF can impair cognitive 
performance.  
The World Health Organisation (WHO) defines health as “a state of complete physical, 
mental and social well-being and not merely the absence of disease or infirmity” (World 
Health Organisation, 1946).While, to date, there is no evidence of any adverse health 
effects of EMF exposure below the established safety guidelines  (Health Canada, 2015; 
Health Council of the Netherlands, 2009; SCENIHR (Scientific Committee on 
Emerging and Newly Identified Health Risks), 2009; World Health Organisation, 2014), 
the prevalence of adverse symptoms attributed to EMF exposure, while currently 
lacking evidence of a direct causal relationship (Röösli et al., 2010; Rubin et al., 2005; 
Rubin et al., 2010), may be viewed by many in the community as a major health effect, 
warranting the need for further investigation. 
1.3  Perceived sensitivity to EMF 
Anecdotal reports of sensitivity to devices which emit EMF began to emerge in the late 




units (VDU) began to arise in Great Britain and Norway, and were followed by similar 
reports in Sweden, the United States and Japan (Lindén & Rolfsen, 1981; Nilsen, 1982; 
World Health Organisation, 2004). As technology progressed, so too did the reports of 
sensitivity to devices which emit EMF, with emitters such as mobile phones and Wi-Fi 
now claimed to adversely affect individuals. While there is currently no established 
diagnostic criterion to identify individuals suffering from IEI-EMF (World Health 
Organisation, 2004), generally, the condition is characterised by a person experiencing a 
broad range of dermatological, neurasthenic, vegetative or mood symptoms (see table 
1.1) which they attribute to the EMF emitted by various electronic and wireless devices 
or infrastructure.  
The difficulty in establishing a clear aetiology for the symptoms reported by IEI-EMF 
sufferers is compounded by the heterogeneous nature of the condition. No consistent 
pattern in either the types of symptoms, the time it takes for symptoms to develop and 
subside or the sources of EMF that are claimed to trigger symptoms has been detected. 
For instance, cross-sectional survey studies and qualitative case studies have shown that 
IEI-EMF symptoms have been reported by sufferers in response to a wide range of 
EMF emitting devices and infrastructure including mobile and cordless phones, mobile 
phone base stations, personal computers, ELF-EMF sources (i.e., power lines, electrical 
appliances and railroads), Wireless Local Area Networks (W-LAN or ‘Wi-Fi”), 
Magnetic Resonance Imaging (MRIs) and Ultra Violet (UV) radiation from sunlight. In 
addition, the sources that people report sensitivity to have been found to be either very 
specific (e.g., they report responding to one source only) or are more general (e.g., they 
report responding to a range of, or ‘all’ EMF sources) (Hagström, Auranen, & Ekman, 




& Braun-Fahrländer, 2004; Schüz et al., 2006). Furthermore, some sufferers report 
experiencing short lasting ‘acute’ symptoms which they allege are in relation to using or 
being in the vicinity of EMF-emitting devices, while others report experiencing more 
prolonged and debilitating symptoms which are claimed to be the result of a build-up of 
exposure from a variety of sources over time (Hocking, 1998, 2014; Röösli et al., 2004). 
As well as experiencing considerable physical impairment, individuals suffering from 
IEI-EMF report a significant degree of social, mental, functional, and financial strain. 
This is often associated with increased levels of distress, increased health service use, 
the desire to move away from cities to areas perceived as ‘safer’ or ‘low-EMF’ and 
being either partly or completely unable to work due to their health issues (Hagström et 
al., 2013; Johansson, Nordin, Heiden, & Sandström, 2010; Kato & Johansson, 2012; 












Table 1.1: Common symptoms reported by IEI-EMF sufferers 




in the head 
Concentration problems 
Memory problems 




















Stinging sensation of the 
skin 
Hot sensations of the head 
region 
 
Table 1.2 displays the estimated prevalence of IEI-EMF in various countries around the 
world. These figures demonstrate that the prevalence of the condition is also relatively 
heterogeneous globally. It is important to note, however, that not all individuals 
attributing health complaints to EMF exposure identify themselves as ‘being EHS’ 
(Kato & Johansson, 2012; Schüz et al., 2006). It is also possible that the difference in 
prevalence rates are reflective of the differences in the type of questions asked and the 
time of the survey being administered, rather than an actual difference in prevalence 




participants to mark factors for which they believed they were hypersensitive or allergic 
to from a range of 13 environmental stimuli (for example pollen, noise, electromagnetic 
fields) at a time when concern about EMF in Sweden was mainly focused on the EMF 
emitted by VDU and powerlines. Conversely, Blettner et al. (2009) conducted a survey 
which focused specifically on symptoms attributed to RF-EMF and asked participants 
whether they were worried about health effects of mobile phone base stations in general, 
and whether they believed that their health was adversely affected by mobile phone base 
stations. Clearly, these two methodologies differ substantially in terms of their focus 
and the time at which they were conducted. As such, the figures presented in Table 1.2 
should be noted with caution, as they may represent an over- or under-estimate of the 
prevalence of the condition. 
Table 1.2: Estimated prevalence of IEI-EMF 
Country Prevalence (%) Source 
Sweden 1.5 (Hillert et al., 2002)  
California 3.2 (Levallois, Neutra, Lee, & Hristova, 2002) 
Austria 3.5 (Schröttner & Leitgeb, 2008) 
Netherlands 3.5 (Baliatsas et al., 2015) 
United Kingdom 4.0 (Eltiti, Wallace, Zougkou, et al., 2007) 
Switzerland 5.0 (Schreier, Huss, & Röösli, 2006) 
Germany ~10 (Blettner et al., 2009) 
Taiwan 13.3 (Tseng, Lin, & Cheng, 2011) 
The distressing and debilitating symptoms experienced by those who suffer from IEI-




(Johansson, Sandström, Heiden, & Nordin, 2010). Clearly, those who experience IEI-
EMF are impaired according to the WHO definition of health, and further investigation 
is required to elucidate the aetiology of their symptoms. Although the characterisation 
of IEI-EMF through qualitative case studies and survey data generates considerable 
insight into how the condition affects people’s lives, such studies cannot objectively 
comment on the existence of a causal relationship between EMF and the reported 
symptoms (Hocking, 1998). Generally, this is because these types of studies do not 
involve an empirical test of whether exposure to EMF can generate the symptoms, but 
instead rely heavily on retrospective self-report, which is known to suffer from recall 
bias (Baliatsas et al., 2015; Vrijheid et al., 2009). Anecdotal reports are also unable to 
account for the possibility that a psychological phenomenon, such as a nocebo effect, 
rather than the EMF exposure itself, is responsible for triggering the reported 
symptoms. As such, these studies cannot provide definitive support for the toxicogenic 
theory of IEI-EMF.  
1.4  The Nocebo Effect  
Medical practitioners have long been aware of a seemingly mysterious phenomenon 
known as a placebo effect. This effect is characterised by a genuine physiological or 
psychological response to a stimulus that has no inherent powers to produce the 
observed effect (Stewart-Williams, 2004; Stewart-Williams & Podd, 2004). The classic 
example of a placebo effect occurs when a patient is prescribed a sugar pill and the 
patient, unaware that the pill is merely a placebo (and is thus pharmacologically 
irrelevant to their complaint), makes a full recovery (Stewart-Williams, 2004). Of 
interest to this thesis, however, is the negative counterpart of the placebo effect, the 




the genuine adverse physiological and psychological effects of stimuli which have no 
inherent powers to produce observed effects (Barsky, Saintfort, Rogers, & Borus, 2002; 
Hahn, 1997; Kennedy, 1961). Importantly, in both placebo and nocebo effects, the 
exposure or substance administered to a person is not a necessary or sufficient cause of 
the associated outcome (Hahn, 1997). 
In comparison to the placebo effect, much less is known about the factors which 
contribute to a nocebo response. Generally, this is because inducing a nocebo response 
is a stressful and anxiety provoking procedure which may lead to a real deterioration in 
health, thus limiting its potential to be ethically investigated in humans (Enck, 
Benedetti, & Schedlowski, 2008). The extensive study of placebo effects has, however, 
revealed the complex interaction between psychological processes, such as expectation 
and anticipation, and particular neuronal systems that are capable of altering the course 
of a symptom or disease (Benedetti, Lanotte, Lopiano, & Colloca, 2007). This has led to 
the formation of a number of theories about the possible factors and neurobiological 
mechanisms that may contribute to a nocebo effect, though determining which 
mechanism sufficiently explains the nocebo effect has not yet been adequately clarified. 
So far, three theories have been proposed to explain the nocebo effect; namely 
misattribution, learning and expectation (Webster, Weinman, & Rubin, 2016).  
The misattribution theory posits that pre-existing symptoms are misattributed to the 
effects of a new exposure (Webster et al., 2016). While it is common to experience 
symptoms in everyday life (Kroenke & Price, 1993; Petrie, Faasse, Crichton, & Grey, 
2014; Reid, Wessely, Crayford, & Hotopf, 2001), when these symptoms are perceived 
to occur consistently with an environmental exposure, the potential to mistakenly 




recent qualitative study suggested that people who claim to suffer from IEI-EMF are 
actually individuals who have pre-existing medically unexplained symptoms (MUS) 
who are using the notion of sensitivity to EMF as a narrative to help explain their 
symptoms (and thereby misattribute their symptoms to EMF) in an effort to make their 
condition more practically and emotionally manageable (Dieudonné, 2016). Some 
researchers, however, argue that misattributing symptoms to an exposure does not 
technically constitute a nocebo effect, and that expectations and/or learning are the 
predominant factors underpinning a nocebo response (Barsky et al., 2002; Colloca & 
Franklin, 2011). This may be because misattribution can be viewed as one step in the 
nocebo process, rather than a nocebo effect itself. Indeed, Dieudonné (2016) did not 
consider the misattribution of MUS to EMF as a nocebo response per se, but rather 
suggested that the misattribution of symptoms occurs independently, and that a nocebo 
response based on negative expectations or learning may occur at a later stage to further 
reinforce the original symptom misattribution. In a recent systematic review, however, 
Webster et al. (2016) showed that a number of studies investigating the nocebo response 
had found that participants who suffered from conditions with symptoms similar to 
those being induced by an inert substance predicted increased symptom reporting, 
demonstrating that the misattribution mechanism of the nocebo effect may be plausible 
in some instances. While misattribution may be an underlying factor in the presentation 
of some IEI-EMF cases, it is a difficult factor to quantify through empirical research, as 
the original symptom misattribution could only be understood through qualitative 
interviews or epidemiological survey studies, which are often conducted retrospectively 
and may be influenced by recall bias. Yet, irrespective of the debate surrounding 




of conscious or subconscious symptom misattribution is an important element in the 
remaining two nocebo effect theories.  
The learning theory suggests that nocebo effects are elicited through classical 
conditioning (Barsky et al., 2002; Webster et al., 2016). For example, a person may 
experience side effects to a prescribed medication, but not because of a pharmacological 
reaction, but rather because they have experienced side effects to drugs with, for 
instance, a similar shape, colour, smell or taste, in the past (Barsky et al., 2002). In this 
way, the physical properties of the medication have acquired the capacity to elicit a 
physiological change as a result of classical conditioning, through either a conscious or 
subconscious mechanism (Webster et al., 2016). In regards to IEI-EMF, it is possible 
that the coincidental experience of a common symptom when a person comes into 
contact with a certain EMF emitting source on a number of occasions forms an 
association in the brain such that when that (or a similar) device is seen, it automatically 
triggers the associated response (i.e. a symptom). In this way, an individual will have 
become conditioned to experience a symptom when they come into contact with that 
specific or similar looking EMF emitting sources or if they come to believe that they are 
in an environment where they are being exposed to EMF. Misattribution may then play 
a role when a person attributes the cause of their symptoms (without any objective 
evidence) to the EMF emitting source as a way of labelling what the conditioning has 
demonstrated.    
The expectation theory proposes that negative expectations of adverse symptoms or 
reactions and the associated emotional states associated with such expectations elicit the 
adverse symptoms or reactions in the expectant person (Hahn, 1997). The possible 




expectations that may drive nocebo responses are anticipation and information about 
negative outcomes, prior experience of negative therapeutic outcomes and the 
observation of other patient’s negative outcomes (Colloca & Franklin, 2011). For 
instance, if a person is given information that an interaction with a (neutral) stimulus 
may have negative side effects (for example a headache), the negative expectation 
generated by this information may make an individual increasingly likely to notice or 
attend to either existing or new symptoms, and then attribute these symptoms to the 
stimulus (Barsky et al., 2002). In addition to this, the emotional states associated with 
negative expectations may also induce that particular negative emotional state. For 
example, the expectation of anxiety is in itself anxiety provoking, and therefore directly 
elicits the negative effect that was expected (Webster et al., 2016). In many instances, 
explicit suggestions about the effects of an exposure have been shown to be a key 
contributing factor in the generation of negative expectations that result in nocebo 
effects (Barsky et al., 2002; Benedetti et al., 2007; Webster et al., 2016). In terms of 
IEI-EMF, an example of this may be that the communication of information about 
potential adverse health effects, either through news media stories or through the 
precautionary information communicated by governments and health agencies, 
constitutes an explicit suggestion which could then be responsible for the formation of 
negative expectations and a subsequent nocebo effect. Yet while many studies have 
shown that explicit suggestions about the effects of EMF can negatively influence 
people’s beliefs about EMF exposure (Barnett, Timotijevic, Shepherd, & Senior, 2007; 
Köteles, Tarján, & Berkes, 2016; Nielsen et al., 2010; Wiedemann, Boerner, & 
Repacholi, 2014; Wiedemann et al., 2013; Wiedemann & Schütz, 2005; Wiedemann, 




induced by such information can result in a symptomatic nocebo response following a 
perceived exposure to EMF has not been sufficiently established. 
Recent studies investigating the potential factors and neurobiological mechanisms 
underlying placebo and nocebo effects mostly stem from the investigation of pain 
processing in healthy participants. Despite the ongoing debate about which theory can 
better explain placebo and nocebo effects, these studies have confirmed that mental 
processes, mediated by expectations and learning, have the ability to modify the 
experience of pain. Further, these changes in pain processing have been able to be 
objectively measured and associated with certain brain regions and 
psychopharmacological processes using neuroimaging methods (Colloca & Franklin, 
2011). In particular, experimental studies have shown that negative verbal suggestions 
following the administration of inert substances can induce anticipatory anxiety about 
the impending pain increase which, in turn, triggers the activation of two different and 
independent biochemical pathways (Benedetti, Amanzio, Vighetti, & Asteggiano, 
2006). One pathway involves the activation of cholecystokinin (CCK), a neuropeptide 
that has been found to play a crucial role in a number of psychological and 
physiological functions (Hebb, Poulin, Roach, Zacharko, & Drolet, 2005), including as 
a neuromodulator in the facilitation of the experience of pain (Benedetti et al., 2007). 
The other pathway involves the activation of the hypothalamic-pituitary-adrenal axis 
(HPA), a pathway implicated in the release of cortisol and the experience of anxiety 
(Benedetti et al., 2006; Benedetti et al., 2007). In addition to this, Landgrebe, Barta, et 
al. (2008) found that a sham EMF exposure administered to people with IEI-EMF 
resulted in symptom experiences that correlated with alterations in neural activity in the 




processing experimentally induced pain. The observation that sham exposures can elicit 
symptoms in IEI-EMF participants is often used to suggest that the symptoms 
experienced are the result of a nocebo effect (Rubin et al., 2010), and the findings of 
Landgrebe, Barta, et al. (2008) provides strong evidence of the neurobiological 
mechanism potentially underlying this response.  
Although there appears to be relatively strong evidence for the ability of psychological 
and neurobiological processes to influence symptom perception via nocebo effects, 
whether this is the case for the symptoms experienced by IEI-EMF sufferer’s remains 
highly contentious. Although Dieudonné (2016) concluded that IEI-EMF does not 
originate from a nocebo response, it is important to note that Dieudonné (2016) did not 
test the cause of the participant’s symptoms, but rather, retrospectively asked 
participants about their beliefs regarding the cause of their symptoms using qualitative 
methods. Retrospective self-reports, especially in relation to the aetiology of symptoms 
associated with EMF exposure, are known to suffer from recall bias (Baliatsas et al., 
2015; Vrijheid et al., 2009), and as such, the conclusions reached by Dieudonné (2016) 
cannot be used to comment on the possibility that IEI-EMF is associated with a nocebo 
effect. As such, only empirical studies, which test for a quantifiable relationship 
between symptoms and exposure, can be used to establish whether IEI-EMF can be 
better explained by a toxicogenic or psychogenic theory. 
1.5  Empirical Studies Investigating Reported Sensitivity to EMF  
Observational epidemiology studies and experimental laboratory studies are the two 
main scientific approaches that have been used to investigate whether humans are 
sensitive to EMF exposure within the established public safety guidelines (for e.g. 




symptom reports and exposure, by estimating the amount of exposure individuals (who 
may or may not believe they are sensitive to EMF exposure) are receiving in their daily 
lives in relation to the type, frequency and severity of non-specific symptoms that they 
experience. Laboratory studies, on the other hand, attempt to deliberately trigger 
symptom responses to specific types and strengths of EMF exposure in a controlled 
setting, and generally focus specifically on individuals who report experiencing IEI-
EMF. Both of these approaches have a number of strengths and limitations, all of which 
must be taken into account when assessing our current understanding of IEI-EMF.  
Although some researchers and IEI-EMF advocacy groups have suggested that studies 
utilising ‘subjective’ measures of symptoms are scientifically unreliable (Leszcynski, 
2018), there is also no reliable evidence showing that IEI-EMF sufferers experience any 
consistent physiological responses as a result of exposure to EMF (Rubin, Hillert, 
Nieto-Hernandez, van Rongen, & Oftedal, 2011). As no consistent pattern of 
objectively measurable changes resulting from EMF exposure can be used to 
characterise or diagnose IEI-EMF, epidemiological and laboratory studies must rely on 
participant self-report. The use of self-report measures in IEI-EMF studies is, however, 
appropriate because IEI-EMF sufferers report subjective changes which they associate 
with perceived exposure to EMF, they do not rely on objective data of disease from 
situations where exposure is and is not present and then conclude that one causes the 
other. 
While sensitivity to a whole range of devices which emit different types of EMF has 
been reported (as discussed in section 1.3), much of the recent literature has been 
focused on investigating the potential adverse effects of exposure to RF-EMF emitted 




increasingly ubiquitous and have been the cause of most concern in recent times. In line 
with this, and in an effort to provide focus for the present doctoral research, the 
remainder of this thesis will focus on the possible relationship between RF-EMF 
exposure and IEI-EMF. 
1.5.1  Epidemiological studies 
Epidemiology is the study of the distribution and causes of human disease in free living 
populations; that is, the study of disease in populations that are not under the constraints 
of a laboratory environment. Epidemiological studies either measure the frequency of 
diseases or other health related characteristics in populations in order to observe 
whether such frequencies vary with other characteristics, or they assess whether 
associations exist between possible causative factors and health outcomes (Elwood, 
2017). As epidemiological studies require large sample sizes to account for error 
variance, studies investigating the possible causal association between RF-EMF 
emissions and symptoms have mostly recruited participants from the general population 
(and may or may not have included IEI-EMF participants). These epidemiological 
studies typically examine whether there is an association between mobile phone base 
stations and symptoms. Although the lack of focus on IEI-EMF participants may be 
viewed as a major limitation for establishing whether symptoms attributed to EMF are 
associated with exposure, one of the major benefits of these studies (over laboratory 
studies) is that they allow for the investigation of longer exposure periods and symptom 
outcomes in large samples under normal living conditions, and thus may be useful for 
providing evidence (if any) of a potential association between EMF exposure and 




Over the past two decades, a number of epidemiological studies have been conducted, 
with varying methods and results. Notably, two studies reported significant associations 
between symptoms and exposure to EMF. Hutter, Moshammer, Wallner, and Kundi 
(2006) investigated the relation between RF-EMF exposure and several measures of 
cognitive performance, well-being and sleep quality, in individuals living near 10 
selected base stations. Spot measurements in the bedrooms of participants and a 
calculation of distance to the mobile phone base station were used to estimate exposure 
rates. Although it was found that exposure rates in the participant’s homes were far 
below the recommended standards, the results showed a significant relationship 
between exposure level and headache score. Symptom ratings were also found to be 
higher in participants expressing concerns about health effects from the base station. 
Similarly, Abdel-Rassoul et al. (2007), using a cross-sectional study, reported a 
significantly higher prevalence of reported neuropsychiatric complaints, including 
headache, in people living or working near a base station than in matched controls. 
However, the measurement of RF-EMF exposure was made 4 years before the study 
was conducted and only in one area where some of the experimental participants were 
located, and no attempt was made to measure exposure in the control group. Therefore, 
the results of this study are unable to comment on the relationship between exposure 
and symptoms. 
While there has been some limited evidence of an association between symptom reports 
and exposure, the majority of epidemiology studies assessing the potential association 
between symptom reports and exposure have failed to find such an association (Röösli 
et al., 2010). For instance, Thomas et al. (2008) did not find any significant association 




required to wear personal dosimeters for a 24 hour period. In addition to this, in a large 
cross-sectional study which used dosimeters to measure RF-EMF in the bedrooms of 
participants, Berg-Beckhoff et al. (2009) found no association between RF-EMF 
exposure and a range of health outcomes including sleep quality, headache, 
psychosomatic complaints, mental and physical health or chronic stress. Moreover, 
Baliatsas et al. (2015) did not find an association between everyday life RF-EMF 
exposure, and non-specific symptoms or sleep quality.  
Although epidemiological studies attempt to bridge the gap between the anecdotal 
reports of symptoms in response to EMF exposure and the controlled laboratory studies 
investigating the causal role of EMF exposure in producing symptoms, these studies 
face serious methodological limitations, especially in regards to exposure 
characterisation. Many studies rely on the historical reconstruction of exposure history 
or the individual’s perceived distance to an exposure source to estimate how much 
exposure a person has received, but this is prone to recall bias and often does not take 
into account the variety of near and far field sources to which people are exposed 
(Baliatsas et al., 2015). In a systematic review of this field, Röösli et al. (2010) found 
that epidemiological studies with crude exposure assessments show health effects, while 
studies with more sophisticated exposure measurements rarely indicate an association. 
The more sophisticated methods of exposure characterisation include the use of spot 
measurements or personal exposure meters. But these again are limited, in that spot 
measurements can only provide information about exposure at specific locations and at 
specific times, while personal exposure meters can be influenced by a number of 
factors; including calibration, body shielding and bias associated with the alteration of 




Consequently, while epidemiological studies vary substantially in both quality and 
outcomes, the limitations associated with such studies make it difficult to determine 
whether exposure to EMF is associated with non-specific symptoms or IEI-EMF itself. 
In support of this, the World Health Organisation has recommended that the aetiology 
of IEI conditions be determined via the results of double-blind, sham-controlled, 
provocation studies, where the ability to discriminate between active and sham 
environmental exposures suggests a toxicogenic mechanism, and inability to 
discriminate suggests a psychogenic mechanism (International Programme on Chemical 
Safety/World Health Organization (IPCS/WHO), 1996). 
1.5.2  Laboratory studies 
Human laboratory studies, often termed ‘provocation studies’, offer a powerful method 
for testing whether the presence of EMF is sufficient to trigger symptoms in humans. 
Provocation studies typically involve volunteers being exposed to active and sham EMF 
under controlled conditions, preferably in a double-blind testing protocol. Typically, 
these studies test whether people who report suffering from IEI-EMF are better at 
detecting EMF than people without the condition (or at greater than chance levels), and 
whether sufferers of IEI-EMF respond to the presence of EMF with increased 
symptoms compared to sham exposures. Over the past two decades, a number of 
provocation studies using varying methodologies simulating either mobile phone base 
station like exposures or mobile phone handset like exposure have been conducted. 
Provocation studies utilising mobile phone base station like exposures attempt to 
simulate the whole body exposures typically experienced in the vicinity of mobile 
phone base stations, whilst studies utilising mobile phone handset like exposures try to 




phone handset in an active talking mode. Generally, provocation studies have failed to 
provide evidence to support the notion that IEI-EMF is a condition directly associated 
with the presence of EMF (Rubin et al., 2005; Rubin et al., 2010).   
One of the first studies conducted investigating the effect of a base station-like exposure 
on well-being in a controlled laboratory setting reported that EMF exposure reduced 
well-being scores in both IEI-EMF and control participants (Zwamborn, Vossen, van 
Leersum, Ouwens, & Makel, 2003). However, in a follow up study using an improved 
methodology and a larger sample size, Regel et al. (2006) failed to find an effect of 
exposure on symptom scores or well-being in either IEI-EMF participants or healthy 
controls, and did not find evidence to suggest that participants could discriminate 
between the active and sham conditions. Interestingly, Eltiti, Wallace, Ridgewell, et al. 
(2007) found that IEI-EMF participants reported an increase in symptoms in an initial 
non-blind active trial, but that when the study was blinded, the increase in symptoms in 
the active trial was not present. The results did show a significant increase in reports of 
arousal during exposure compared to sham, however further analysis revealed that this 
was likely due to a lack of appropriate randomisation and counterbalancing. No other 
effect of exposure in either the IEI-EMF or healthy control group was found. Similarly, 
Wallace et al. (2012) found that IEI-EMF participants reported an increase in symptoms 
in an active base station exposure condition compared to sham in an initial non-blinded 
trial, but found no differences in well-being, symptom levels or discrimination in later 
double-blind trials. In addition to this, Furubayashi et al. (2009) did not find any effect 
of either long or intermittent exposures on measures of mood, discomfort or the ability 
to discriminate between active and sham conditions during a double-blind protocol, in 




Studies investigating mobile phone handset-like exposures and IEI-EMF have also 
generally failed to find any relationship. For example, Wilén, Johansson, Sandström, 
Kalezic, and Lyskov (2006) found no significant effect of RF-EMF exposure on a range 
of physiological or cognitive parameters in either participants who reported mobile 
phone exposure-related symptoms or matched healthy controls. Similarly, Rubin, Hahn, 
Everitt, Cleare, and Wessely (2006) found that while IEI-EMF participants reported 
greater symptom severity than matched controls, IEI-EMF individuals were unable to 
reliably discriminate between the exposure conditions, and the increase in symptoms 
was not dependent on the exposure condition, with the sham condition being sufficient 
to trigger symptoms. Corresponding to this, Oftedal, Straume, Johnsson and Stovner 
(2007) found that the sham condition also triggered symptoms in IEI-EMF participants, 
but did not find any evidence to suggest that either the IEI-EMF or matched control 
groups could accurately detect when they were being actively exposed. In addition, 
Nam et al. (2009) did not find any effect of exposure on subjective symptoms or a range 
of physiological parameters, and IEI-EMF participants were no better at detecting the 
presence of RF-EMF than controls. Moreover, after a subset of participants took part in 
a sleep component of a provocation study, no effect of exposure on self-reported 
sleepiness, fatigue or arousal following sleep was found (Lowden et al., 2011). Finally, 
in a recent study assessing whether IEI-EMF participants were able to correctly identify 
whether they were being exposed to an individually relevant signal (exposures which 
each individual participant reported reacting to) or sham condition, van Moorselaar et 
al. (2017) found that while participants were able verify that they were being exposed in 
an initial non-blinded exposure, subsequent double-blind testing revealed that they were 




Of the few studies that have found significant effects in the IEI-EMF group, 
methodological problems have often confounded the results, including the failure to 
account for multiple significance tests, inadequate counterbalancing or the possible de-
blinding of participants or researchers (Rubin et al., 2010). These confounds appear to 
explain the failure to replicate such results in larger samples. For instance, although 
Hillert et al. (2008) found that neither the IEI-EMF or control group could detect RF-
EMF exposure better than chance, a significant number of participants reported 
headache symptoms more commonly after RF-EMF exposure than sham. However, the 
effect was due to a rise in headache reporting in the control group and the statistical 
analyses were not corrected for multiple tests. In addition to this, one study reported that 
two IEI-EMF participants were able to accurately detect an active exposure condition at 
highly significant rates (Kwon, Koivisto, Laine, & Hamalainen, 2008), however on a 
subsequent retest six months later, the same two participants were unable to replicate 
their results, suggesting that their initial performance was not related to a 
bioelectromagnetic phenomenon (given that the exposures were the same in both 
situations). Moreover, Nieto-Hernandez et al. (2011) reported increased ratings of 
headache and difficulty in concentration in IEI-EMF participants and increased levels of 
headache and fatigue in non-IEI-EMF participants following exposure to a continuous 
wave signal. Concentration difficulties were again reported for the IEI-EMF participants 
after exposure to a pulsed signal. However, after appropriate adjustment for multiple 
comparisons, these results were not significant. Furthermore, McCarty et al. (2011) 
reported that an IEI-EMF participant’s symptoms were associated with exposure 
(specifically, they were related to the field transitions created when switching from 




thus could not be said to be less likely than chance), and the results were not replicated 
(Rubin, Cleare, & Wessely, 2011).   
Like epidemiological studies, provocation studies are challenged by several 
methodological limitations, some of which could potentially explain the inability of 
these studies to find an effect of exposure. One of these limitations relates to 
recruitment. Little is known about whether subsets of the condition exist and so it is 
conceivable that the samples tested may have included a combination of both 
individuals who are sensitive to EMF or to types of EMF not used in the testing 
protocol, and others who may suffer from unrelated conditions. This could result in a 
large amount of noise being added to the data, which would reduce statistical power and 
mask any real effects. Another issue is determining whether the environment that 
provocation studies are conducted in reflects the environment in which IEI-EMF 
individuals report symptoms. Often, studies are conducted in laboratories with 
specialised chambers which block out background electromagnetic fields. While it is 
generally thought that this should increase the chances of detecting an effect, it may 
potentially remove important synergistic elements present in the environment. Anxiety, 
which may be heightened due to participating in a laboratory experiment, may also 
mask any significant effects. Participants may have also encountered other EMF 
exposures on the way to the experimental session which inadvertently trigger symptoms 
(Rubin, Hahn, et al., 2006; Rubin et al., 2010). This again, would mask any potential 
significant effects from being discovered. Criticism has also been raised concerning the 
relevance of simulated RF-EMF signals used in many of these studies to participant’s 
reported symptoms (Panagopoulos, Johansson, & Carlo, 2015). Yet, the evidence so far 




similarity of the exposure (and irrespective of the exposure status), which suggests that 
this is not an important confound. Likewise, although it has been suggested that 
symptom onset and offsets have not been matched in experimental studies, there is no 
evidence that this has confounded previous research either. Finally, while a number of 
studies have consistently demonstrated that the symptoms experienced by IEI-EMF 
sufferers are likely the result of a nocebo effect, few studies have investigated the 
underlying mechanisms which may contribute to such a response. It is important to 
note, however, that although these methodological issues are often used by IEI-EMF 
advocacy groups to argue that it is premature to rule out the role of EMF in the 
presentation of IEI-EMF, there is no evidence to demonstrate that these issues have 
influenced the results of previous studies. 
1.6 Thesis Rationale and Aim 
Clearly, IEI-EMF is a complex condition which is not adequately understood by current 
scientific models. In stark contrast to the anecdotal reports of sensitivity to EMF (see 
section 1.3), a considerable number of epidemiological and laboratory studies have 
failed to find evidence for a relationship between EMF exposure and IEI-EMF (see 
section 1.5 for review). While the majority of IEI-EMF sufferers believe that the 
condition is caused by exposure to EMF, much of the existing empirical literature 
indicates that the condition is more closely associated with a nocebo effect, where 
conscious or subconscious symptom expectation following a perceived exposure to 
EMF leads to the formation or the presentation of symptoms (Hillert et al., 2008; 
Landgrebe, Frick, et al., 2008; Oftedal et al., 2007; Rubin et al., 2010). While the 
discrepancy between the anecdotal reports of sensitivity to EMF and the scientific 




to experience distressing and debilitating symptoms with no reliable, evidence-based 
treatment options or support. Considering that those who suffer from IEI-EMF could 
not be considered healthy according to the WHO definition of health (World Health 
Organisation, 1946), further research is required to clearly determine the aetiology of 
their symptoms. 
The fundamental issue at the centre of the aetiological debate is whether the associated 
symptoms can be explained by a toxicogenic or psychogenic theory. The toxicogenic 
theory of IEI-EMF proposes that the presentation of adverse symptoms is the result of 
an intolerance or susceptibility to exposure to low levels of EMF, which then affect the 
body via an as-yet-unrecognised bioelectromagnetic pathway (Rubin et al., 2010; 
Staudenmayer et al., 2003a). Alternatively, the psychogenic theory of IEI-EMF suggests 
that the condition can be explained by an individual’s overvalued belief of harm, a 
belief which is shaped by psychological, psychosocial and psychophysiological 
processes (Staudenmayer et al., 2003b) and which culminates in the presentation of 
adverse symptoms via a nocebo response. However, due to a number of potential 
methodological limitations, and a general lack of understanding of the possible 
mechanisms underlying toxicogenic and psychogenic explanations of IEI-EMF, it is 
difficult to conclusively determine the aetiology of IEI-EMF on the basis of the 
currently available evidence. 
The overall aim of the present doctoral research is to clarify the determinants of IEI-
EMF by investigating whether toxicogenic or psychogenic processes can explain the 
symptoms reported by IEI-EMF sufferers. Specifically, the research contained in this 
thesis encompasses three human provocation studies designed with methodological 




exposure to EMF and to examine the potential psychological mechanisms which may 
underlie IEI-EMF sufferers’ perception that they are sensitive to EMF exposure. 
This thesis is presented as a collection of manuscripts prepared for publication in accord 
with the requirements of the University of Wollongong (Thesis by Compilation). Each 
chapter represents a manuscript written for a specific journal with a defined audience. 
Each chapter begins with a Chapter Foreword which outlines the rationale, aims and 
significance of each manuscript, and establishes a link between each manuscript and the 
thesis aims more generally. The structure of the abstract and headings within each paper 
is consistent with the style used by the journal for which it is written. Chapter 2 has 
been published in the International Journal for Radiation Biology, Chapter 3 has been 
published in Bioelectromagnetics and Chapter 4 has been published in Environmental 
Research. While each journal requires a specific referencing style, for consistency all 
chapters in this thesis are referenced in the current style of the American Psychological 
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2.  CHAPTER 2: PULSE MODULATED RADIOFREQUENCY 
EXPOSURE INFLUENCES COGNITIVE PERFORMANCE 
2.1  Chapter Foreword 
Despite decades of research, IEI-EMF provocation studies have generally failed to 
provide evidence that the symptoms reported by IEI-EMF sufferers are associated with 
EMF exposure. While many IEI-EMF sufferers and advocacy groups have raised 
concerns that subjective measures of belief of exposure and self-reported symptoms in 
provocation studies are ‘scientifically unreliable’, objective tests of sensitivity to EMF 
are currently lacking, as there have been no consistent reports of adverse effects of EMF 
exposure on endpoints that are relevant to health. Although a number of studies have 
consistently reported physiological effects of exposure to RF-EMF on the brain’s 
electrical activity (see section 1.2 for review), these effects may not necessarily reflect 
an adverse health outcome, as many of these (and other) studies assessing various 
aspects of cognitive and behavioural functioning have found inconsistent, but mostly 
null results. Given the close relationship between the brain’s electrical activity and 
cognition, and given that IEI-EMF sufferers often report memory and concentration 
difficulties as symptoms which they attribute to EMF exposure, this may offer a 
potentially useful avenue for research.  
It is possible that a number of methodological issues have limited the ability of previous 
studies to detect effects of RF-EMF exposure on cognitive performance. These issues 
include the use of poor exposure protocols and experimental designs, inadequate sample 
sizes and cognitive performance measures which may not have adequately accounted 
for confounding variables. Given these methodological limitations, it remains unclear 




EMF exposure on cognitive performance endpoints can be established, then this may 
offer a starting point for determining the most sensitive objective endpoints to test IEI-
EMF participants.  
In an attempt to improve methodology and identify possible impairments on measures 
of cognitive performance, the study presented in this chapter aimed to determine 
whether exposure to mobile phone-like RF-EMF exposure could influence cognitive 
performance, and whether it does so in a dose-dependent manner. Although this does 
not directly test the claim that IEI-EMF symptoms are associated with EMF exposure, it 
is a useful first step for developing a potentially sensitive endpoint that may then be 
used to test IEI-EMF participants, while also overcoming criticisms that empirical 
studies investigating IEI-EMF need to utilise objective tests of sensitivity. This paper 
has been published in the International Journal of Radiation Biology. 
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Purpose: To investigate whether exposure to pulse modulated radiofrequency (PM RF) 
influences human cognitive performance, and whether it does so in a dose dependent 
manner. 
Materials and Methods: Thirty six healthy adults participated in a randomised, double 
blind, counterbalanced provocation study. Cognitive performance was assessed using a 
visual discrimination task and a modified Sternberg working memory task, which were 
calibrated to individual performance levels in a preliminary testing session. An sXh920 
planar exposure system was used to generate a 920 MHz GSM-like signal, providing 
three conditions (peak-spatial SAR averaged over 10g) of 0 W/kg (Sham), 1 W/kg (Low 
RF) and 2 W/kg (High RF). 
Results: A significant decrease in reaction time (RT) in the Sternberg working memory 
task was found during exposure compared to Sham. This effect was not dose dependent.  
Conclusions: PM RF exposure was shown to influence cognitive performance in a 
working memory task. While the majority of the literature has not found effects of PM 
RF exposure on cognitive performance, it is possible that the methodological 
improvements employed in the present study increased sensitivity, and thus the ability 





Over the past two decades, the increasingly widespread use of mobile phones has 
generated growing concern about potential adverse effects that the radiofrequency 
electromagnetic fields (RF-EMF) emitted by these devices could have on human health. 
While a number of independent reviews have concluded that there are no substantiated 
health effects associated with exposure to mobile phone RF-EMF (Health Canada, 
2015; Health Council of the Netherlands, 2009; SCENIHR (Scientific Committee on 
Emerging and Newly Identified Health Risks), 2009; World Health Organisation, 2014), 
there is evidence which indicates that exposure can influence the brain’s electrical 
activity. Specifically, it has been consistently shown that pulse modulated RF (PM RF) 
affects spontaneous resting alpha (8-12 Hz) (Croft et al., 2008; Croft et al., 2010; Curcio 
et al., 2005; Leung et al., 2011; Perentos, Croft, McKenzie, Cvetkovic, & Cosic, 2007; 
Regel, Gottselig, et al., 2007) and sleep spindle activity (approximately 11-15 Hz) in 
non-rapid eye movement sleep (Huber et al., 2000; Huber et al., 2002; Loughran et al., 
2005; Regel, Tinguely, et al., 2007; Schmid et al., 2012).  
However, the functional consequence of this change in EEG activity remains unclear, as 
studies assessing aspects of cognitive and behavioural functioning during and following 
exposure to PM RF have produced contradictory, but mostly null results (Barth, 
Ponocny, Gnambs, & Winker, 2012; Valentini, Ferrara, Presaghi, De Gennaro, & 
Curcio, 2010).  
One measure of cognitive performance which has yielded inconsistent results is 
working memory performance, which has been primarily assessed using the N-back 
task. Three studies have reported decreases in reaction time (Koivisto, Krause, 




et al., 2007) and one study reported an improvement in accuracy (Regel, Tinguely, et 
al., 2007). The majority of studies using this task, however, have  not found any effects 
of PM RF exposure on performance (Haarala et al., 2003; Haarala et al., 2004; Haarala 
et al., 2007; Krause, Pesonen, Bjornberg, & Hamalainen, 2007; Leung et al., 2011).  
The difficulty in establishing a firm conclusion as to whether PM RF influences 
cognitive performance may be attributed to a number of methodological constraints. For 
example, the variation in methods between research groups makes it difficult to 
compare or verify previous results, while poor exposure protocols and experimental 
designs, inadequate sample sizes and a lack of reliable cognitive performance measures 
have limited the potential for finding an effect (Regel & Achermann, 2011). Several 
other issues may have also contributed to the mixed findings. For instance individual 
differences in cognitive performance have not been adequately accounted for in 
previous studies. It is also possible that the N-back task is not sensitive enough to 
adequately detect changes in cognitive performance as a result of PM RF exposure 
(Regel & Achermann, 2011) as it has been shown that this task can be significantly 
influenced by learning effects (Haarala et al., 2005; Haarala et al., 2004; Regel, 
Gottselig, et al., 2007; Regel, Tinguely, et al., 2007). Furthermore, as the only known 
interaction between RF-EMF exposure and the body is via heating (Adair & Black, 
2003), thermally induced variability may have also influenced the results. In addition, 
the localised, intermittent exposure protocols utilised by some research groups may not 
have been sufficiently powerful to produce an effect (Boutry et al., 2008). These factors 
have the potential to introduce large amounts of error variance, which may have masked 




In order to overcome these issues, the present study has been designed with several 
methodological improvements to examine whether exposure to PM RF influences 
cognitive performance in a dose dependent manner. In particular, a visual 
discrimination task and a modified Sternberg working memory task (Sternberg, 1966) 
were employed, both of which were calibrated to individual performance levels in a 
preliminary testing session. The study also utilised a planar patch antenna system to 
ensure that there was a consistent, uniform exposure across the target hemisphere. 
Thermally induced variability was reduced by clamping skin temperature to a thermo-
neutral level. In addition to these improvements, the cognitive performance data was 
treated using an index of the participants’ response sensitivity and bias, as adapted from 
signal detection theory (Stanislaw & Todorov, 1999). This treatment takes into account 
how well a participant can discriminate between trials (sensitivity) and the participant’s 
general tendency to respond with a ‘yes’ or ‘no’ button press (bias), giving a better 
indication of task accuracy and minimising Type I and Type II error. Further to the 
double-blind, counterbalanced, sham-controlled design; these improvements were 
implemented to increase sensitivity, and thus, the possibility of finding potential effects. 
The results of the present study are part of a larger study investigating the effect of PM 





2.4 Materials and Methods 
2.4.1 Participants 
Forty-three participants were recruited through advertisements and word of mouth. 
Seven participants failed to attend all testing sessions, leaving thirty-six participants 
(half male) aged 18 – 52 years (M = 24.44; SD = 6.27). To be included in the study, 
participants were required to be between 18 and 55 years of age, be right handed and 
report being of good health. Participants were excluded from the study if they reported 
having a current illness or medical condition, or having used illicit substances within the 
7-day period prior to the study. Suitable participants were required to attend the 
Illawarra Health and Medical Research Institute, University of Wollongong, for four 
mutually convenient testing sessions, at the same time of day and separated by a period 
of at least 7 days. The study was approved by the Human Research Ethics Committee 
(University of Wollongong: HE13/146), and written, informed consent was obtained 
from all participants. All participants were instructed to abstain from alcohol for at least 
8 hr before the commencement of a testing session, abstain from caffeine for at least 1 
hour before a testing session, and to not use their mobile phone for at least 2 hr before 
the beginning of a testing session. All participants were compensated a total of $200 for 
their involvement in the study. 
2.4.2 Radiofrequency exposure  
An sXh920 planar exposure system (IT’IS Foundation, Zurich, Switzerland) was used 
to generate a 920 MHz GSM-like signal (as emitted by a mobile phone handset in active 
mode while transmitting voice). The signal included the basic GSM frequency 
components (8.33, 216.6, 1733 Hz, including corresponding harmonics; crest factor = 




above the ear canal at a distance of 115 mm from the head (Huber et al., 2002; Huber et 
al., 2005; Loughran et al., 2013). The RF exposure of the sXh920 system has been fully 
characterised and was calibrated to provide a peak-spatial SAR averaged over 10g of 0 
W/kg, 1 W/kg and 2 W/kg, for the Sham, Low and High exposure conditions 
respectively (for full dosimetric data see Murbach, Christopoulou, Crespo-Valero, 
Achermann, and Kuster (2012)). These exposures were within the Australian general 
public RF exposure limits (ARPANSA RPS3). The system was controlled electronically 
using defined participant numbers. The fully randomised and counterbalanced exposure 
conditions were assigned to each participant and pre-programmed by a researcher not 
involved in the collection of data (RC) to ensure that double-blinding was maintained. 
An inbuilt failsafe mechanism ensured RF levels did not exceed RPS3 levels. Only the 
left hemisphere was exposed to RF, and brown noise was used to mask any sounds 
made by the exposure system in order to ensure that participants were not aware of the 
exposure condition. At the completion of each experimental testing session, participants 
were asked whether they were aware of the exposure status and the side of exposure via 
a pen and paper Likert scale (1 = ‘left’, 2 = ‘right’, 3 = ‘both’, 4 = ‘no’, 5 = ‘don’t 
know’) and an open ended question asking for further details about their ability to 
perceive the exposure (‘If yes, how did you perceive the field?’).   
2.4.3 Design 
A double-blind, counterbalanced, cross-over design was employed. Following a 
preliminary calibration session, each participant’s cognitive performance was tested 
under three conditions (Sham, Low and High RF) during exposure (block 1) and 
following exposure (block 2) over three separate sessions separated by at least seven 




made aware of which antenna was emitting. Order of exposure was counterbalanced 
across participants and randomly assigned.  
2.4.4 Cognitive Performance Tasks 
Two tasks were used to assess cognitive performance. These tasks were calibrated to 
each participant’s individual level of performance in a preliminary testing session and 
sufficiently long practice blocks were utilised prior to each experimental session to 
reduce learning, floor and ceiling effects. Behavioural outcomes were measured as the 
number of correct hits, correct rejections, false alarms and false rejections, as well as 
participant’s reaction time (RT) to correct responses.  
2.4.4.1 Visual discrimination task. Visual perception was assessed using a visual 
discrimination task. A series of crossed white lines were presented in the centre of a 
computer monitor with a black background for 200ms each. Between each stimulus 
presentation, a mask appeared for 500ms, followed by a blank screen for 300ms. Figure 




Figure 2.1: Examples of the stimuli used in the visual discrimination task. (a) Is an 
example of an easy target stimulus, (b) is an example of a difficult target stimulus (c) is a 




For each stimulus presentation, participants were asked to respond as quickly and 
accurately as possible via a ‘yes’ button press with the right thumb if they thought that 
the lines differed in thickness (target stimulus), or not to respond if they thought that the 
lines did not differ in thickness (non-target stimulus). A total of 180 stimuli were 
presented (half targets). The frequency and presentation of the target stimuli were 
pseudo-randomised across trials and balanced between blocks. 
Task difficulty was manipulated by increasing the magnitude of thickness between the 
two lines in target stimuli. The greater the difference between the two lines, the easier 
the trial. In target stimuli, one line was kept at a constant thickness of 1.5 mm while the 
second line was manipulated in increments of 0.05 mm. In non-target stimuli, both lines 
were kept constant at 1.5 mm. 
2.4.4.2 Sternberg working memory task. Working memory performance was assessed 
using a modified Sternberg working memory task (Sternberg, 1966). The task involved 
memorising a stimulus set, maintaining that stimulus set in memory during a 3 second 
retention period, and recalling whether a subsequent probe stimulus was in the original 
memory set. The memory sets ranged in difficulty level from 6 to 15 letters.  
The memory sets were constructed from a pool of 21 consonants (B, C, D, F, G, H, J, K, 
L, M, N, P, Q, R, S, T, V, W, X, Y and Z) presented simultaneously in a horizontal 
arrangement over two lines. The letters were 66pt, capitalised, black and in bold Calibri 
font and presented in a centred 6.24 x 25.40 cm grey box on a black background. Each 
letter was spaced 2 cm apart.  
Figure 2.2 outlines the Sternberg working memory task design and progression for each 




possible with a button press using the right thumb if the probe consonant appeared in 
the preceding memory set (target), or to not respond if the probe consonant was not 
presented in the memory set (non-target). Maximum response time was set at 2 seconds. 
40 memory sets were presented (half targets). The frequency and presentation of the 
probe stimuli were pseudo-randomised across trials and balanced between blocks. The 
position of the target probe stimuli in the memory set was also pseudo-randomised 







Retention Probe & 
Response 
Pause 
Figure 2.2: The modified Sternberg working memory task design and progression. A 
fixation cross (800 ms) was followed by a 1000 ms pause. The memory set was then 
presented (4000 ms) and was followed by a blank screen retention period (3000 ms). 
Following this, a probe stimulus appeared (2000 ms) during which time participants had to 
respond with a button press if the probe was present in the preceding memory set, or not 
respond if the probe was not present in the preceding memory set. A blank screen pause 




2.4.4.3 Cognitive Task Calibration. For each participant, the cognitive tasks were 
calibrated during a preliminary testing session, to ensure that the tasks were at a level 
which was difficult, yet still achievable. In the visual discrimination task, the level of 
difficulty was defined as the two most difficult line manipulations that resulted in a 
response sensitivity score of 0.8 and 0.6, corresponding to the easy and difficult 
versions of the task respectively. In the Sternberg working memory task, this level was 
defined as the most difficult stimulus set that resulted in a response sensitivity value of 
0.8. To attain this value, participants completed four blocks. A five minute break 
separated each of the calibration blocks. In all blocks, the visual discrimination task 
preceded the Sternberg working memory task. During the calibration session, 
participants were not exposed to RF and no physiological data was recorded.  
2.4.5 EEG and thermo-physiological apparatus 
A water perfusion garment (Grant Instruments Ltd., Cambridge, U.K.) was used to 
clamp body skin temperature to 34 °C to produce a thermo-neutral environment. The 
water perfusion suit was made of cotton and enclosed a series of pipes which distributed 
water across the skin at a rate of 2.5L/min at a temperature of 34 °C. The garment 
covered the torso, arms, waist and legs. Water temperature was controlled using a 
digital thermostat (Type: GD120, Grant Instruments Ltd., Cambridge, U.K.) which 
could heat or cool water accordingly to 34 °C ± .02°C. A range of physiological 
measures, including core body temperature, skin temperature, blood pressure, resting 
EEG and cutaneous blood flow to the left hand were also acquired. These measures are 





Participants arrived at the laboratory at either 09:00 or 13:00, with the start time for all 
experimental sessions kept constant within-subjects to minimise circadian effects. 
Participants then completed a 16-item visual analogue mood scale (VAMS) and a series 
of short questionnaires asking about sleep, caffeine and alcohol consumption and 
mobile phone usage before being fitted with the water perfusion suit, EEG and 
physiological recording apparatus. 
Participants were then seated inside a Faraday cage in front of a Dell U2311H LCD 
monitor between the two RF antennas and the water perfusion suit was switched on. 
Participants were positioned such that their eyes were approximately 90 cm from and at 
the same height as the centre of the computer screen. The plane of the monitor was 
perpendicular to both the floor and the sagittal plane of the participants. Participants 
then completed a practice version of the visual discrimination and modified Sternberg 
working memory tasks (2.5 min each). 
Once setup was complete, participants completed a 16 min ‘Baseline’ block, during 
which they were not exposed to RF. During this block participants completed an EOG 
correction task (Croft, Chandler, Barry, Cooper, & Clarke, 2005) and resting EEG and 
physiological data were also recorded.  
The Baseline block was followed by two 30 min experimental blocks, the first block 
being ‘RF-ON’ (Sham, Low or High RF depending on counterbalancing) and the 
second ‘RF-OFF’(post-exposure), with a 1 min break between each block. At the 
beginning of the experimental blocks, resting EEG and physiological measures were 
recorded. Subsequent to this, participants completed the cognitive battery; consisting of 




Sternberg working memory task, with a 1 min break between tasks. Following the 
cognitive tasks, EEG and physiological data were again recorded.  
At the completion of testing, all monitoring equipment was disconnected and the 
participant completed a 16 item VAMS and an exposure condition questionnaire. This 
procedure was repeated for the remaining testing sessions.  
2.4.7 Data analyses 
Behavioural measures were defined as mean reaction time to correctly identified target 
probes (‘RT’) recorded in ms, as well as the number of correct hits, correct rejections, 
false alarms and false rejections 100-900 ms post stimulus in the visual discrimination 
task and 100-2000 ms post probe stimulus in the Sternberg working memory task. 
Response sensitivity (Grier’s A’) and response bias (Grier’s B”) were used to assess 
task accuracy. All data points were converted to z scores for analysis.  
Where a participant performed at below 55% accuracy in the visual discrimination task 
or 50% accuracy in the Sternberg working memory task, data points were interpolated 
in order to preserve counterbalancing. This criterion affected 1 participant (3 blocks) in 
the difficult version of the visual discrimination task, and 6 participants (12 blocks) in 
the Sternberg working memory task. 
Data points were missing for a further 2 participants (2 blocks for 1 participant, 1 block 
for 1 participant) in the visual discrimination task due to the incorrect difficulty level 
being administered. The missing data points were interpolated in order to preserve 
counterbalancing.  
Statistical analyses were performed with SPSS statistical package 21.0. Paired samples t 




response bias overall (comparing the 0 W/kg condition against the average of the 1 
W/kg and 2 W/kg conditions) and whether these effects depended on the dose of 
exposure (comparing the 1 W/kg condition against the 2 W/kg condition). Exploratory 
paired samples t tests were also conducted on non-interpolated data. To correct 
normality, square root transformations were computed for the response sensitivity data 
in the easy version of the visual discrimination task. 
2.5 Results 
2.5.1 RF Status 
Overall, there was a greater tendency for participants to rate the exposure as being off 
(50.93%) or unsure as to whether it was on or off (37.05%) than on (12.03%). The 
participants were unable to detect the RF status better than chance with 18.52% 
correctly identified trials. No participant was able to correctly identify all 3 exposure 
conditions.  
2.5.2 Cognitive Tasks 
The mean RTs and standard deviations for each cognitive task and the significance of 
each paired samples t test are presented in Table 2.1. As shown in Figure 2.3, there was 
significant decrease in RT in the Sternberg working memory task during the exposure 
conditions compared to Sham, t (35) = 2.070, p = .046, r2 = .109. This effect, however, 
was not significant using non-interpolated data (p = .052). No other RT effects were 
detected in either the visual discrimination tasks or the Sternberg working memory task 
when comparing Sham against the exposure conditions or the Low against the High RF 




The mean response sensitivity and standard deviations for each cognitive task and the 
significance of each paired samples t test are presented in Table 2.2. There were no 
significant differences in response sensitivity when comparing Sham against the 
exposure conditions or the Low against the High RF condition, either during or 
following exposure. 
The mean response bias and standard deviations for each cognitive task and the 
significance of each paired samples t test are presented in Table 2.3. There were no 
significant differences in response bias when comparing Sham against the exposure 






Table 2.1: Mean reaction times (ms) and standard deviations for each cognitive task in 
each exposure condition with p values for Sham vs Exposure and Low vs High 
comparisons (values significant at p < .05 are in bold). 













Sham 358 (42) 359 (45) 368 (39) 362 (63) 877 (136) 367 (148) 
Low RF 360 (42) 350 (37) 377 (63) 364 (45) 833 (138) 872 (140) 
High RF 359 (42) 356 (37) 374 (42) 367 (36) 833 (130) 873 (138) 
p values       
Sham vs Exposure .762 .207 .192 .330 .045 .845 
Low vs High .850 .162 .870 .436 .989 .983 
 
Table 2.2: Mean response sensitivity (Grier’s A’) and standard deviations for each 
cognitive task in each exposure condition with p values for Sham vs Exposure and Low 
vs High comparisons. 













Sham .94 (.04) .94 (.05) .91 (.09) .90 (.08) .85 (.10) .86 (.07) 
Low RF .94 (.06) .94 (.06) .91 (.08) .91 (.08) .85 (.08) .85 (.09) 
High RF .93 (.06) .94 (.05) .92 (.07) .91 (.08) .86 (.07) .86 (.07) 
p values 
      
Sham vs Exposure .454 .741 .528 .078 .758 .515 






Table 2.3: Mean response bias (Grier’s B’’) and standard deviations for each cognitive 
task in each exposure condition with p values for Sham vs Exposure and Low vs High 
comparisons. 













Sham .10 (50) .08 (.52) .25 (.45) .23 (.46) .28 (.36) .29 (.28) 
Low RF .14 (.48) .07 (.52) .30 (.41) .28 (.45) .25 (.33) .25 (.29) 
High RF .11 (.50) .08 (.41) .22 (.32) .21 (.43) .28 (.32) .30 (.30) 
p values 
      
Sham vs Exposure .583 .964 .882 .842 .863 .636 
























* p = .046 
Figure 2.3: Mean reaction times (ms) in the Sternberg working memory task as a 
function of condition and block (BL1: during exposure, BL2: post exposure). Paired 
samples t tests showed a significant decrease in reaction time during exposure when 




2.6 Discussion  
The results of the present study indicate that exposure to PM RF influences cognitive 
performance in the Sternberg working memory task. Specifically, a significant decrease 
in RT was revealed during the active exposure conditions compared to Sham. This 
suggests that exposure to PM RF may have a positive influence on cognitive 
performance. This effect, however, was not found to be dose dependent. While the 
exploratory analysis revealed that this effect was not significant using the non-
interpolated data, the interpolation was used to preserve the sample size and 
counterbalancing. Therefore, because the non-interpolated data set contained fewer 
participants, the significance of this effect was expected to be reduced in the non-
interpolated dataset.  
While the present study’s findings are consistent with early reports that exposure to PM 
RF affects working memory performance (Koivisto et al., 2000; Regel, Gottselig, et al., 
2007; Regel, Tinguely, et al., 2007), the majority of the literature has not found such an 
influence (Haarala et al., 2003; Haarala et al., 2004; Haarala et al., 2007; Krause et al., 
2007; Leung et al., 2011). Although we cannot be conclusive, a number of reasons 
related to the methodological improvements employed by this study may explain the 
results. 
The working memory task used in the present study differs markedly from the N-back 
task, which is the task that has been typically utilised in provocation studies assessing 
the effect of PM RF exposure on working memory performance. It seems that the N-
back task was used primarily because of its perceived face validity and (in latter studies) 
as a means to replicate previously reported effects. The problem, however, is that the N-




memory performance, as well as learning, floor and ceiling effects. These confounds 
have the potential to add large amounts of noise to the data, thereby masking potentially 
real effects. The Sternberg working memory task overcomes these confounds by 
utilising a greater number of difficulty levels to calibrate the task to each individual’s 
cognitive ability. This calibration, alongside sufficiently long practice blocks prior to 
each experimental session, increases sensitivity and thus the ability to detect any 
potential effect of PM RF exposure on working memory performance. 
To date, only one other study has accounted for individual differences in working 
memory performance by tailoring cognitive task difficulty to participants’ individual 
ability. After calibrating the N-back task to a level which was ‘difficult, but achievable 
for each participant,’ Leung et al. (2011) did not find any difference in accuracy or RT 
during PM RF exposure compared to Sham. However, in a 3G (W-CDMA) condition, 
Leung et al. (2011) found a significant decrease in accuracy in an adolescent group 
compared to Sham. The present study was able to control for a greater amount of 
variation in individual differences in performance, and thus remove the noise which 
may have masked any effects. 
As the only known mechanism of interaction between RF and the human body is 
thermal (Adair & Black, 2003), it is possible that whole body thermoregulatory 
processes play an important role in mediating the changes in the brain’s electrical 
activity and any potentially associated functional effects resulting from exposure to PM 
RF. To reduce thermally induced variability, the present study clamped skin 
temperature to a thermo-neutral state. As this is the first study to attempt to reduce the 




Variation in exposure setups and SAR profiles and a lack of detailed dosimetric data has 
made it difficult to compare and replicate previously reported effects (Boutry et al., 
2008; Regel & Achermann, 2011). While it is possible that certain brain regions need to 
be adequately exposed to PM RF to produce an effect, it should be noted that because 
the SAR distribution produced by the present planar exposure system is more 
homogenous than mobile phone hand-set exposure, this present exposure differs 
significantly to the more localised exposure produced by a typical mobile phone. 
Therefore, the results of this study can only reflect whether RF related bioeffects can 
occur at the maximum exposure level anywhere within the exposed hemisphere 
(Loughran, McKenzie, Anderson, McIntosh, & Croft, 2008). Thus, the present study 
cannot definitively comment on whether cognitive performance is influenced by PM RF 
emitted by mobile phones, nor can it comment on the effect of long term exposure or the 
effect of exposure on different age groups within the population. Indeed, the World 
Health Organisation has identified research investigating acute effects of PM RF 
exposure on cognition and EEG with children as a priority. While some studies have not 
found effects of PM RF exposure on cognitive performance in children and adolescents 
(Haarala et al., 2005; Leung et al., 2011; Preece et al., 2005), the methodology used in 
the present study may prove to be more sensitive, and should be considered in future 
research with children.  
A number of factors may have limited this study. First, while the statistical analysis 
controlled for comparison-wise error by restricting the planned contrasts to degrees of 
freedom error (without multiple comparison adjustment) (Tabachnick & Fidell, 2013), 
this method does not control for experiment-wise error. Second, it is possible that the 




occur has been explored in great detail and is unlikely to have influenced the results. 
Generally, EEG electrode leads have been found to produce a shielding effect, reducing 
the SAR in head regions close to the antenna and also where the maximum value is 
obtained. The reduction in SAR tends to be less than 20% (Hamblin et al., 2007; 
Murbach, Neufeld, Christopoulou, Achermann, & Kuster, 2014). These findings 
indicate that electrode configurations do not act like an antenna, and therefore do not 
enhance SAR. Furthermore, as the reductions have been found to be less than 20%, 
electrode configurations are also not thought to greatly attenuate SAR to the point 
where results are influenced (Hamblin et al., 2007; Murbach et al., 2014). 
Whether small variations in performance on cognitive tasks as a result of exposure to 
PM RF constitute any meaningful effects in real life situations remains a valid question. 
In a critical review of this field, Regel and Achermann (2011) hypothesise that if such 
elementary motor reactions are influenced by exposure to PM RF, effects on higher 
cognitive functions may be even stronger. It is also possible, however, that the 
significant cognitive performance effects found in some RF-EMF provocation studies 
have occurred unpredictably and independent of task type (Regel & Achermann, 2011). 
This may explain why the significant differences found in the present study only 
occurred in one cognitive task on one variable. But while the results of the present study 
indicate that there is a slight change in performance, it is important that the 
methodology implemented in this study is replicated before determining whether such 
an effect is meaningful. 
In conclusion, the present study has shown that PM RF exposure influences cognitive 
performance in a working memory task. While the majority of the literature has not 




methodological improvements employed in the present study increased sensitivity, and 
thus the ability to detect potential effects. However, as this is the first PM RF 
provocation study to implement these improvements, replication is required in order to 
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3.  CHAPTER 3: IEI-EMF PROVOCATION CASE STUDIES: A 
NOVEL APPROACH TO TESTING SENSITIVE 
INDIVIDUALS 
3.1 Chapter Foreword 
Despite accounting for a number of methodological limitations, as no clear evidence of 
adverse effects was demonstrated in Study 1, the study failed to identify any sensitive 
health-relevant cognitive performance endpoints with which to test IEI-EMF 
participants. In light of this outcome, a change of focus for investigating the 
determinants of IEI-EMF was required. 
While provocation studies offer one of the most powerful methods for testing the claims 
of IEI-EMF sufferers, these studies have been heavily criticised by many IEI-EMF 
advocacy groups and a minority of researchers. These criticisms are often related to 
questions about whether laboratory testing environments adequately reflect the 
conditions in which symptoms normally develop, and a failure of previous studies to 
account for the heterogeneous nature of the condition. While there is currently no 
empirical evidence to suggest that such issues have affected the outcomes of previous 
studies, as these criticisms are often used to suggest that provocation studies are 
inappropriate for investigating the symptom claims of IEI-EMF sufferers, it is clear that 
an improved provocation study design is needed in order to adequately determine the 
aetiology of the condition.  
The study presented in this chapter (Study 2) incorporated a number of methodological 
improvements designed to specifically address the potential methodological issues that 




of IEI-EMF. The study aimed to determine whether IEI-EMF symptoms are more 
closely related to EMF exposure or a nocebo effect. This chapter has been published in 
the journal Bioelectromagnetics. 
Verrender, A., Loughran, S.P, Anderson, V., Hillert, L., Rubin, G.J, Oftedal, G., & 
Croft, R.J (2018). IEI-EMF provocation case studies: A novel approach to testing 





3.2  Abstract 
The aetiology of Idiopathic Environmental Intolerance attributed to Electromagnetic 
Fields (IEI-EMF) is controversial. While the majority of studies have indicated that 
there is no relationship between EMF exposure and the symptoms reported by IEI-EMF 
sufferers, concerns about methodological issues have been raised. Addressing these 
concerns, the present experiment was designed as a series of individual case studies to 
determine whether there is a relationship between RF-EMF exposure and an IEI-EMF 
individual’s self-reported symptoms. Three participants aged 44-64 were tested during a 
series of sham and active exposure trials (2 open-label trials; 12 randomised, double-
blind, counterbalanced trials), where symptom severity and exposure detection were 
scored using 100mm visual analogue scales. The RF-EMF exposure was a 902-928 
MHz spread spectrum digitally modulated signal with an average radiated power output 
of 1 W (incident power density at the participant 0.3 W/m2). In the double-blind trials, 
no significant difference in symptom severity or exposure detection was found for any 
of the participants between the two conditions. Belief of exposure strongly predicted 
symptom severity score for all participants. Despite accounting for several possible 
limitations, the present experiment failed to show a relationship between RF-EMF 






A proportion of the population report experiencing a wide range of non-specific 
symptoms which they attribute to the electromagnetic fields (EMF) emitted by various 
electronic and wireless technologies. Commonly referred to as Electromagnetic 
Hypersensitivity (EHS), the condition is characterised by a variety of dermatological, 
neurasthenic and/or vegetative symptoms, with headaches, nausea, skin irritations, 
fatigue and concentration difficulties amongst the most commonly reported symptoms 
(Hagström, Auranen, & Ekman, 2013; Hillert, Berglind, Arnetz, & Bellander, 2002; 
Kato & Johansson, 2012; Röösli, Moser, Baldinini, Meier, & Braun-Fahrländer, 2004). 
Generally, the reported symptoms are claimed to be triggered by technologies which 
emit EMF in the radiofrequency (RF-EMF) and extremely low frequency (ELF-EMF) 
domains of the non-ionizing radiation spectrum, at levels well below the thresholds 
known to cause adverse health effects in humans (ICNIRP, 1998, 2010). These devices 
include mobile phones and their base-stations, Wi-Fi, electricity transmission and 
distribution systems, and ‘smart’ meters. The condition can have major implications for 
an individual’s quality of life and is often associated with decrements in general health 
status, increased levels of distress, increased levels of health service use and serious 
impairments in occupational and social functioning (Johansson, Sandström, Heiden, & 
Nordin, 2010). 
Yet, despite the considerable prevalence of the condition globally (estimated to be 
between 1.5 – 13.5%) (Baliatsas et al., 2015; Blettner et al., 2009; Eltiti, Wallace, 
Zougkou, et al., 2007; Hillert et al., 2002; Levallois, Neutra, Lee, & Hristova, 2002; 
Schreier, Huss, & Röösli, 2006; Schröttner & Leitgeb, 2008; Tseng, Lin, & Cheng, 




relationship between exposure to EMF and the non-specific symptoms reported by EHS 
individuals (Health Canada, 2015; Health Council of the Netherlands, 2009; Röösli, 
Frei, Mohler, & Hug, 2010; Rubin, Das Munshi, & Wessely, 2005; Rubin, Nieto-
Hernandez, & Wessely, 2010; Scientific Committee on Emerging and Newly Idenified 
Health Risks, 2015). This discrepancy between the scientific consensus and the 
subjective reports of sensitivity to EMF not only limits the treatment options and 
support for those who experience EHS, but also leaves some members of the public 
feeling uncertain and anxious about potential adverse health effects of EMF exposure. 
Due to the lack of evidence for an association between exposure to EMF and EHS, the 
World Health Organization recommended that the term Idiopathic Environmental 
Intolerance attributed to Electromagnetic Fields (IEI-EMF) be used in place of EHS to 
avoid implying a causal role of EMF in producing the reported symptoms (World 
Health Organisation, 2004). 
Experimental provocation studies have been predominately used as a means of 
investigating IEI-EMF. In these studies, a participant is exposed to both active and sham 
EMF under controlled, preferably double-blinded protocols, while their symptomatic 
response to each condition is monitored. Over the past decade, a number of provocation 
studies using a range of EMF and varying methodologies have failed to provide 
sufficient evidence to support the view that IEI-EMF is directly associated with 
exposure to EMF (Rubin et al., 2010; Scientific Committee on Emerging and Newly 
Idenified Health Risks, 2015; World Health Organisation, 2014). Indeed, sham 
exposures alone have been found to be sufficient to trigger symptoms in IEI-EMF 
participants (Nam et al., 2009; Oftedal, Straume, Johnsson, & Stovner, 2007; Wilén, 




increase in symptoms in an initial non-blinded active exposure condition, compared to 
sham, but have then found no significant differences between active and sham 
conditions in subsequent double-blind trials (Eltiti, Wallace, Ridgewell, et al., 2007; 
Wallace et al., 2012). Similarly, a recent study reported that IEI-EMF participants were 
unable to correctly identify when they were being exposed under double-blind 
conditions, despite an initial verification that they could detect active from sham 
conditions in an open-label trial (van Moorselaar et al., 2017). These findings have led 
many to suggest that IEI-EMF may be the result of a nocebo response, where conscious 
or subconscious symptom expectation following a perceived exposure to EMF leads to 
the formation or detection of symptoms (Hillert et al., 2008; Landgrebe et al., 2008; 
Oftedal et al., 2007; Rubin et al., 2010). Recent findings from a qualitative study, 
however, suggest that instead of the condition originating from a nocebo response, IEI-
EMF individuals may be using the notion of sensitivity to EMF to provide a narrative to 
explain their medically unexplained symptoms (MUS) in an effort to make their 
condition more practically and emotionally manageable (Dieudonné, 2016).  
Although the reviews cited above have failed to support the view that EMF exposure 
was related to symptoms in self-diagnosed IEI-EMF participants, it is important to note 
that there are a number of studies that have claimed to identify such relations, and which 
are often used in support of the claim that there is a causal relation. However, such 
studies do not provide the claimed support, but are more easily explicable in terms of 
methodological considerations. For example, McCarty et al. (2011) claimed an effect of 
on-off electric field transitions, but as the study was later criticised for lacking clear 
methodology, and given that it has not been replicated, this cannot be taken as evidence 




reported that two healthy participants were able to detect EMF at greater than chance 
levels, but they could not replicate their results in the same individuals a month later, 
which suggests that whatever caused the initial significant results, it is unlikely that it 
was due to a bioelectromagnetic phenomenon.  
In line with the focus on methodology, both advocacy groups and some researchers 
have argued that the null results are due to methodological limitations, such as a failure 
to account for the heterogeneous nature of the condition and the way in which 
participants have been selected and tested. For example, it is possible that the samples 
tested have included a combination of both individuals who are sensitive to EMF and 
others who may suffer from unrelated conditions (Rubin et al., 2010). This is 
problematic, as the majority of studies have taken a nomothetic approach to testing IEI-
EMF, and have therefore relied on group means which may have had potentially 
reduced statistical power due to the noise added to the analysis from non-responders. In 
addition, few studies have tested whether the exposure signal used was relevant in 
eliciting symptoms for each individual in the sample, which again may have potentially 
made the RF-EMF exposure irrelevant for many of the participants. Furthermore, while 
the experience of IEI-EMF is known to vary considerably between individuals in terms 
of the type and severity of symptoms experienced and the amount of time required for 
symptoms to develop and subside following exposure (Hocking, 1998; Röösli et al., 
2004), the majority of provocation studies have not taken this heterogeneity into 
account. Instead, studies have generally used relatively standard exposure and wash-out 
periods across all participants, which, without verification of an open-label effect using 
the particular study protocol, may again make the protocol irrelevant to the reported 




Concerns have also been raised about whether the testing environments of provocation 
studies adequately reflect the conditions in which IEI-EMF individuals report 
symptoms. It is possible, for instance, that the laboratory setting has caused some 
participants to experience anxiety, which may have then affected their symptom 
response. It is also possible, on the assumption that there is a relation between EMF and 
symptoms, that participants have encountered other EMF exposures on the way to an 
experimental session which have then inadvertently triggered symptoms (Rubin et al., 
2010). If symptoms had been triggered by external factors prior to the experimental 
manipulation, this would also increase the error variance and potentially mask any real 
effects. However, although it is logically possible that these limitations have masked 
real effects of EMF on symptoms, it is important to point out that there is no 
substantiated evidence that this is the case; such issues need to be determined 
empirically. 
In light of this, the present experiment was designed as a series of individual case 
studies to determine whether there is a relationship between RF-EMF and an IEI-EMF 
individual’s self-reported symptoms, employing several important methodological 
improvements in order to overcome potential limitations of previous studies. First, the 
study utilised a portable exposure device which enabled double-blind testing to take 
place in environments where participants generally felt safe and asymptomatic, such as 
in their own home. This was implemented in order to reduce the stress and anxiety 
which may be experienced by a participant in a laboratory setting, while also reducing 
potential confounding effects associated with inadvertent exposures to environmental 
EMF emissions on the way to an institutional testing location. Second, the methodology 




included using a similar RF-EMF exposure to the one which the participant claimed 
triggers symptoms, and both the exposure source and reported symptoms were 
individually verified in an initial open-label, non-blinded trial. This limits potential 
‘non-responder’ data from statistically confounding ‘responder’ data. Further to this, the 
study included a consideration of the reported symptom onset and recovery periods, 
such that the testing regime, if necessary, could be modified to incorporate these. A 
sufficient number of sham and exposure conditions were also used to determine 
statistically, within the individual, whether any symptom/exposure relation was 
significant. Finally, the design incorporated a fully counter-balanced protocol in order to 
reduce time of day and time on task effects. The aim of the study was first to test 
whether exposure to RF-EMF from the portable exposure device resulted in an increase 
in an IEI-EMF participant’s nominated symptom compared to sham, and second, to 
determine whether IEI-EMF participants could detect the active RF-EMF signal at 
greater than chance levels, under double-blind conditions. 
3.4 Materials and Methods 
3.4.1 Participants  
In total, twenty-five potential participants contacted the research centre during the 
recruitment period. Of these, three participants aged 44-64 (two male) completed the 
study. Six participants were excluded from the study in an initial phone screen due to 
not meeting the eligibility criteria. The remaining sixteen participants either expressed 
that they did not want to continue participation in the study (after receiving a participant 
information sheet and speaking with the researchers via telephone) or could not be re-




Participants were recruited through advertisements on the research centre website and 
via a press release in the local newspaper and television network. All participants were 
first screened via a telephone interview to confirm eligibility for the study. To be 
included in the study, participants must have reported one or more acute symptoms 
which they attributed to the use of or to their personal proximity to mobile phone or Wi-
Fi devices. Acute symptoms were defined as any symptom with an onset time of less 
than 30 min and which took less than 2 hr to subside following exposure, and that could 
be self-managed without the need of a health professional. Participants must have also 
self-diagnosed or labelled themselves as having EHS or IEI-EMF for greater than 1 
year. Participants were excluded from the study if they reported any serious medical or 
psychological illnesses, or indicated that they used recreational illicit drugs.   
A mutually convenient testing time was arranged with suitable participants. The study 
was approved by the Human Research Ethics Committee (University of Wollongong: 
HE15/160), and informed written consent was obtained from all participants. 
3.4.2 Radiofrequency Exposure 
RF exposure was generated using a portable, self-contained, battery-operated device 
(Two Fields Consulting, St Kilda, Australia). The RF device was placed 30 cm from the 
participant (either on the side or to the front depending on what was comfortable for the 
participant) on a hard surface. The main exposure from the device was a spread 
spectrum RF signal in the 902-928 MHz ISM band which was digitally modulated in a 
similar manner to signals from Wi-Fi and 3G and 4G mobile phones. The RF signal was 
generated by a commercial RF modem which emitted a frequency hopping spread 
spectrum signal with an average radiated power output of 1 W for 30 min, or was 




side of the device facing the participant was measured using a calibrated broadband 
instrument with an uncertainty of ±2.4 dB for a two-sided coverage interval and a 
coverage factor of 2 (Narda EMR 300 meter and Type 9 E-field probe, Narda Safety 
Test Solutions, Hauppauge, NY), and was found to be 0.3 W/m². This RF exposure 
level is below the power density reference level limit of 4.6 W/m² specified for the 
Australian general public (ARPANSA RPS3) and by the ICNIRP (1998). It is important 
to note that the maximum localised specific absorption rate (SAR) from the exposure 
device used in the present study is less than that which typically results from personal 
mobile phone use (held against the ear in the active taking mode) due to the greater 
separation distance. Conversely, the whole body averaged SAR and localised SAR of 
the device used in the present study is greater than that which normally results from Wi-
Fi and mobile phone base station signals. The device was fully enclosed in a thermally 
insulated case and coded inputs were used to maintain double-blinding. The device 
contained an independent RF monitor to check the status of the RF transmitter and each 
use of the device was logged using internal memory. The fields emanating during the 
RF-ON exposure and sham conditions were demonstrated to each participant in the 
open-label trial using a Nardalert S3 broadband monitor (Narda Safety Test Solutions, 
Hauppauge, NY). This monitor was then removed for the subsequent double-blind 
testing.  
3.4.3 Questionnaires 
3.4.3.1 Demographic and health questionnaire  
Demographic and health screening questionnaires were used to capture data on the age, 
handedness, education level, gender, general medical condition, and caffeine, tobacco, 




3.4.3.2 Symptom history questionnaire 
Two open ended questions were used to assess each participant’s symptom history. 
These were “What are the two most immediate EMF symptoms you experience?” and 
“Do you suffer from any debilitating EMF symptoms?” Participants were asked to 
include information on the source perceived to be responsible for triggering the 
symptoms, the symptom severity, the time of onset and the time needed for the 
symptom to subside, the first time the symptom was experienced and any treatment 
methods used to relieve the symptom. Participants were also asked to indicate any other 
EMF symptoms which they regularly experienced on a checkbox list of 11 common 
IEI-EMF symptoms (Rubin, Hahn, Everitt, Cleare, & Wessely, 2006). 
3.4.3.3 WHOQOL-BREF 
The WHOQOL-BREF (World Health Organisation, 1998) assesses how disease impairs 
the subjective well-being of a person across a range of domains. The questionnaire 
comprises 26 items, which measure quality of life in the following broad domains: 
physical health, psychological health, social relationships, and environment. 
3.4.4 Symptom and Exposure Status Scale (SESS) 
During the provocation trials, participants were asked to indicate symptom severity and 
exposure status via pen and paper 100mm visual analogue scales. Participants were 
asked “how sure are you of the current exposure status right now?” anchored with the 
terms ‘Definitely OFF’ and ‘Definitely ON’, and “how strong/unpleasant is your 
nominated symptom right now?” anchored with the terms ‘Barely Detectable’ and 
‘Maximum Severity’. While a full symptom history was obtained from each participant 
prior to testing, the symptom tested in the double-blind trials was defined as the most 




3.4.5 Design  
Each participant’s symptom severity and exposure detection ability was tested under a 
series of 14 sham and active provocation trials. On the first day of testing, two open-
label trials (1 RF-OFF, 1 RF-ON) were conducted, where both the participant and the 
researcher were aware of the exposure status. This was used to determine whether the 
exposure device could trigger individually-relevant symptoms in each participant. If a 
participant did not report symptoms or was unable to detect the exposure in the RF-ON 
condition in this initial test, their participation in the experiment ceased at this point. 
The initial open-label trials were followed by a series of 12 double-blind, randomised, 
counterbalanced trials, consisting of 6 sham and 6 RF-ON exposure conditions. This 
was achieved using the Excel randomization command, such that a sham and RF-ON 
condition were treated as a pair; the conditions of each pair were randomly allocated 
before assigning the next pair; where more than two sequential pairs had the same order 
the third pair was replaced with the alternate pair order; and no more than three of the 
same pair-order were permitted. In total, each trial ran for 105 min (except for the RF-
OFF open-label trial, where there was no post-trial assessment or rest interval as there 
had been no exposure). For each participant, the 14 trials took 24 hr to complete, spread 
over a period of 3 consecutive days (the number of RF-ON and sham trials were 
matched within each day). 
3.4.6 Testing Location 
Testing was conducted in a safe, asymptomatic environment (determined by the 
participant) in order to reduce stress and to reduce any confounding effects due to 
environmental RF emissions. In all three cases, participants chose (and were tested in) 





Upon arrival at the participant’s home, the researchers set up the exposure device in a 
comfortable area and ensured that all known electronic and RF emitting devices were 
switched off. All participants were then given a verbal description of the ensuing 
session before completing demographic and health screening questionnaires. To begin 
the provocation trials, participants were asked to sit comfortably in a chair with the 
exposure device placed approximately 30 cm from them (either to the side or in front of 
them, depending on what was comfortable for the participant). The progression of each 
provocation trial is shown in Figure 3.1. The first day of testing began with two open-
label trials. The first open-label trial was an RF-OFF (sham) trial, which began with a 
15 min baseline interval (no exposure; status known to participant and researcher) to 
assess the participant’s symptom severity pre-trial. The SESS was completed at the 1- 
and 14-min mark (B1 and B2) of the trial. This was followed by a 30 min exposure 
interval, where the exposure device was switched to an RF-OFF (sham) setting 
(exposure status known to the participant and researcher) and the SESS was again 
completed at the 16-, 30- and 44-min mark of the trial (E1, E2 and E3). The RF-OFF 
open-label trial was immediately followed by the RF-ON (active) open-label trial. 
Again, a 15 min baseline interval (no exposure; status known to participant and 
researcher) was used to assess the participant’s symptom severity pre-trial.  The SESS 
was completed at the 1- and 14-min mark (B1 and B2) of the trial. This was followed by 
a 30 min exposure interval where the exposure device was switched to an RF-ON 
setting (exposure status known to the participant and researcher) and the SESS was 
completed at 16-, 30- and 44-min mark (E1, E2 and E3) of the trial. The exposure 
interval was then followed by a 30-min post-exposure assessment (no exposure; status 




46-, 60- and 74-min mark (PE1, PE2 and PE3) of the trial. The post-exposure interval 
was followed by a 30 min rest interval, where the participant was free to move around, 
rest and consume food and water before the onset of the next trial. The subsequent 12 
double-blind trials followed the same progression as the open-label RF-ON trial, except 
that during the exposure interval, the exposure device was set to either sham or RF-ON 
(status unknown to the participant and researcher) depending on randomization and 
counterbalancing.  
  
Figure 3.1: Provocation trial design. Each trial begins with a 15 min Baseline (B) interval, 
followed by a 30 min Exposure (E) interval, a 30 min Post-Exposure (PE) interval and a 30 
min Rest interval, with a total trial time of 105 min. Arrows represent the time points where 





3.4.8 Statistical Analysis 
Statistical analyses were performed with SPSS Statistics for Windows 21.0 (IBM, 
Armonk, New York). For each individual, a Mann-Whitney U test was used to assess 
the difference in symptom severity and exposure detection ability, comparing the 6 
sham to the 6 RF-ON double-blind exposure conditions (which are treated as 
independent). This provides power (0.80) to detect effect sizes of > 1.6 with an alpha = 
0.05, which is consistent with the (anecdotal) reports of effect sizes from IEI-EMF 
sufferers (who claim to be able to reliably detect and/or suffer symptoms from EMF). It 
is important to note that there are currently no effect sizes related to actual effects of 
exposure, which is why one based on anecdotal reports of IEI-EMF has been used. The 
primary dependent variable was the difference between the baseline score at 14 min of 
the trial (B2) and the exposure score at 44 min of the trial (E3), for both symptom 
severity and exposure detection. A difference score was used to minimise the influence 
of baseline variability and potential carry-over effects. In order to determine the 
magnitude of the effect induced by the open-label exposure for each participant, an 
effect size was calculated, based on the difference in symptom severity for the RF-ON 
and RF-OFF condition. However, because there is no measure of variability in the open-
label trial, the experimental double-blind data was used to calculate a standard 
deviation. To achieve this, the effect of belief of exposure first needed to be removed. 
To do this, a simple linear regression was conducted to predict symptom score based on 
how confident each participant was that the exposure was on or off in the double-blind 
trials (belief of exposure), and unstandardised residuals were calculated. The 
unstandardised residuals were then used to calculate the standard deviation, which could 
then be used in the effect size calculation of the open-label trials. These linear 




between belief and symptom severity for each participant via the resultant r-squared 
values. 
3.5 Results 
3.5.1 General health status 
The participants did not report any severe medical or psychological conditions. One 
participant reported suffering from tinnitus and one participant was on thyroid hormone 
replacement therapy but was clinically euthyroid at the time of the tests. 
3.5.2 Effect size in the open-label trials  
Confirming that the open-label manipulation had worked in each case, all of the 
calculated effect sizes in the open-label trials were extremely large (P01 = 5.97, P02 = 
3.66, P03 = 6.98), and much larger than the traditionally used nomenclature of Cohen 
(1988), which treats the largest category of effect size as >.5. 
3.5.3 Participant 1 (P01): 
3.5.3.1 Symptom history 
The two most common immediate symptoms the participant reported experiencing in 
response to EMF were headache (severity 8/10) and dizziness (severity 8/10), with an 
onset time of 10 min and taking up to 2 h to subside. The two most common debilitating 
symptoms reported by the participant were Vertigo (with an onset time of 12 to 24 hr 
following exposure and taking up to 2 days to subside), and confusing thoughts (onset 
time and time needed to subside not known). The participant also reported experiencing 
nausea, fatigue, eye pain, skin itching, sensation of burning on the skin, memory loss, 
insomnia and immune system deficiency. These symptoms were attributed to mobile 




developed 5 years prior to testing. Although the participant reported a number of 
symptoms, headache was reported as the immediate symptom in the RF-ON open-label 
trial and used as the symptom assessed in the double-blind trials.  
3.5.3.2 Exposure Detection and Symptom Provocation 
Open-label trial: The results of the open-label trial are shown in Figure 3.2a. In the RF-
ON condition, the participant was confident that the exposure device was emitting RF, 
and experienced an increase in symptom severity from baseline throughout the trial. As 
shown in Figure 3.2a, the severity of these symptoms gradually decreased during the 
post-exposure interval. These results indicate that the participant developed symptoms 
and reported detecting the active RF signal. A gradual decrease in symptom severity 
post-exposure was also observed. The participant did not detect the presence of RF or 
exhibit an increase in symptom severity in the RF-OFF condition. 
Double-blind trials: The results of the double-blind trials are shown in Figure 3.2b. 
Symptom severity (Median =14.00 versus 34.00, U = 15.00, z = -.481, p = .699, r = 
.139) and detection ability (Median = 54.50 versus 86.50, U = 17.50, z = -.087, p = 
.930, r = .025) did not differ significantly between the RF-ON and sham trials 
respectively. The regression analysis showed that ‘belief of exposure’ significantly 
predicts symptom severity (F(1, 10) = 48.799, p < .001; R2 = .830). 
3.5.3.3 WHOQOL-BREF 
As shown in Table 3.1, the participant’s overall quality of life, physical health, 
psychological health and overall health scores are below the mean population norm (but 
within one standard deviation). The social relationships and environment scores are 




3.5.4 Participant 2 (P02): 
3.5.4.1 Symptom history 
The two most common immediate symptoms the participant reported experiencing in 
response to EMF were feelings of ‘induced hangover’ with an onset time of 30 s to 5 
min (severity 5/10) and a burning sensation in the throat (severity 5/10) with an onset 
time of 4 to 5 min. The participant reported that the time symptoms take to subside can 
vary substantially depending on the exposure, but estimated a range of between 30 min 
to 4 hr. No debilitating symptoms were reported by the participant. The participant also 
reported experiencing eye pain and spots on the face. The reported symptoms were 
attributed to mobile phones and developed 16 years prior to testing. Although the 
participant reported a number of symptoms, a burning sensation in the throat was 
reported as the immediate symptom in the RF-ON open-label trial and was therefore 
used as the symptom assessed in the double-blind trials. 
3.5.4.2 Exposure Detection and Symptom Provocation 
Open-label trial: The results of the open-label trial are shown in Figure 3.2c. In the RF-
ON condition, the participant was confident that the exposure device was emitting RF, 
and experienced an increase in symptom severity from baseline throughout the trial. The 
severity of this symptom fluctuated during the post-exposure interval. These results 
indicate that the participant developed an individually relevant symptom and reported 
the presence of the active RF exposure. In the RF-OFF trial, the participant did not 
report the presence of RF but a slight increase in symptom severity was also observed. 
Double-blind trials: The results of the double-blind trials are shown in Figure 3.2d. 
Symptom severity (Median = 6.50 versus 2.50, U = 14.00, z = -.656, p = .512, r = .189) 




.462) did not differ significantly between the RF-ON and sham trials respectively. The 
regression analysis showed that ‘belief of exposure’ significantly predicts symptom 
severity (F(1, 10) = 79.290, p < .001; R2 = .888). 
3.5.4.3 WHOQOL-BREF 
As shown in Table 3.1, the participant’s overall quality of life score is below the 
population norm, overall health score above the population norm, and the remaining 
domains are within the population norms. 
3.5.5 Participant 3 (P03): 
3.5.5.1 Symptom history 
The two most common immediate symptoms the participant reported experiencing in 
response to EMF were feelings of pain and strain in the head and ears with an onset 
time of 1 to 5 min (severity 5/10), which they attributed to Wi-Fi. The participant 
reported that these symptoms subside within 5 to 15 min. The participant also indicated 
that they experience headache, mild dizziness, fatigue, tinnitus, and “sensations which 
self-highlight in the knees, elbows, tendons and lower arms” which they attributed to 
EMF exposure. The participant also reported experiencing a heavy head and eyelids, 
memory loss, pain and strain, and a tingling sensation attributed to EMF from 
television, however, the symptomatic response to EMF from television was unable to be 
tested in the current protocol. The reported symptoms developed at least 12 years prior 
to testing. Although the participant reported a number of symptoms, a feeling of pain 
and strain in the head and ears was reported as the immediate symptom in the RF-ON 





3.5.5.2 Exposure Detection and Symptom Provocation 
Open-label trial: The results of the open-label trial are shown in Figure 3.2e. In the RF-
ON trial, the participant was confident that the exposure device was emitting RF and 
they experienced an increase in symptom severity during the trial. The severity of this 
symptom decreased during the post-exposure interval. In the RF-OFF trial, the 
participant did not report the presence of RF but there was a decrease in symptom 
severity from baseline. These results indicate that the participant developed symptoms 
and reported detecting the presence of RF during the RF-ON exposure trial. 
Double-blind trials: The results of the double-blind trials are shown in Figure 3.2f. 
Symptom severity (Median = 0.50 versus 1, U = 17.50, z = -.082, p = .935, r = .024) 
and detection ability (Median = 50.50 versus 47.00, U = 12.00, z = -.966, p = .334, r = 
.288) did not differ significantly between the RF-ON and sham conditions respectively. 
The regression analysis showed that ‘belief of exposure’ significantly predicts symptom 
severity (F(1, 10) = 34.093, p < .001; R2 =.773). 
3.5.5.3 WHOQOL-BREF 
As shown in Table 3.1, the participant’s overall quality of life is below the population 
norm, their psychological health, social relationships, physical health and environment 
scores are well below the population norms, and their overall health score is below the 







Table 3.1: WHOQOL-BREF participant domain scores and mean population norms. 













Overall Quality of Life 4 3 3 4.3 (0.8) 
Overall Health 2 5 3 3.6 (0.9) 
Physical Health 63 81 88 80.0 (17.1) 
Psychological Health 69 63 38 72.6 (14.2) 
Social Relationships 81 56 0 72.2 (18.5) 





Figure 3.2: Mean exposure detection and symptom severity scores across the Baseline 
(B1 – B2), Exposure (E1 – E3) and Post Exposure (PE1 – PE3) intervals for P01, P02 and 
P03 are shown, for the open-label (RF-ON and OFF) [left column; a, c, e] and double-




3.6 Discussion and Conclusions 
A number of methodological issues have been raised by both IEI-EMF advocacy groups 
and researchers as possible explanations for why provocation studies have generally 
failed to provide evidence of a relationship between EMF exposure and IEI-EMF 
symptoms. The present study was designed as a series of individual case studies which 
incorporated several methodological improvements to overcome limitations of previous 
studies. In order to determine whether these methodological improvements were 
adequate in providing the necessary conditions to test IEI-EMF participants, an initial 
open-label trial was conducted in each case.  
Crucially, the results of these open-label trials show that the limitations of previous 
studies were sufficiently dealt with. Specifically, the testing environment and the type 
of exposure used were shown to be sufficient to produce the individually relevant 
symptoms which each participant self-nominated as being due to exposure to EMF and 
for each participant to report that RF exposure was indeed active in the RF-ON trial. 
This is important, as it confirms that the environment, RF-EMF exposure device and 
emitting EMF strength used in the study was relevant for eliciting symptoms for these 
particular IEI-EMF individuals. In addition, the observed increase in symptoms over the 
30 min open-label active exposure interval (on average) shows that the exposure 
interval was sufficient to evoke relevant symptoms in each participant, while the 
reduction in symptoms in the post-exposure interval demonstrates that the time course 
of each trial was sufficient to allow symptoms to subside prior to the next trial. The 
effect sizes observed in the open-label trials in each case were also extremely large 
(greater than 3.6), and much larger than the traditionally used nomenclature of Cohen 




verify that the protocol used in the present study was appropriate for testing the sample 
of IEI-EMF individuals.  
While all three participants displayed an increased symptom severity and were 
confident that they could detect the presence of RF-EMF in the RF-ON exposure 
condition compared to RF-OFF in the initial open-label trial, no significant differences 
in symptom severity or exposure detection between the RF-ON and sham conditions 
were found in the double-blind trials. These findings correspond to those reported by 
Eltiti, Wallace, Ridgewell, et al. (2007) and Wallace et al. (2012), who found that IEI-
EMF participants had a greater symptomatic response in an initial open-label active trial 
compared to sham, but no difference in subsequent double-blind trials. Likewise, in a 
study similar to the present investigation, van Moorselaar et al. (2017) reported that IEI-
EMF participants were unable to correctly identify when they were being exposed 
during double-blind testing, despite participants reacting to the exposure in an initial un-
blinded test. Generally, the results of the present experiment agree with the majority of 
previous studies, which have not found any relationship between IEI-EMF symptoms 
and EMF exposure in double-blind provocation paradigms (Rubin et al., 2005; Rubin et 
al., 2010). 
Interestingly, belief of exposure was found to significantly predict symptom severity, 
with belief accounting for 83, 89 and 77 percent of the variance for Participants 1, 2 and 
3 respectively. This may explain why a sham exposure is sufficient to trigger symptoms, 
as has been reported previously (Nam et al., 2009; Oftedal et al., 2007; Wilén et al., 
2006). The strength of belief was particularly noteworthy in Participant 3, who reported 
that the experiment was designed with a deception element. As a result the participant 




despite specific instruction from both the participant information sheet and the 
researchers throughout the trial that the RF exposure was switched off during the post-
exposure interval.  
Although varied, each participant also scored lower than the general population in terms 
of overall quality of life and other measures of health on the WHO-QOL BREF 
questionnaire. This is consistent with the conclusions of many cross-sectional survey 
studies (Hagström et al., 2013; Johansson et al., 2010; Kato & Johansson, 2012), and 
highlights that, in addition to physical impairment, IEI-EMF can significantly impact 
daily functioning and quality of life. This emphasises the importance of developing 
appropriate treatments and support for these individuals, but given the strong belief 
within the IEI-EMF community that EMF is a cause of their symptoms, this will remain 
challenging.  
The results of the present study are limited by a number of factors. First, the results of 
the study cannot be generalised across the entire IEI-EMF population due the relatively 
small sample size. Despite intending to recruit a larger sample, it seems that scepticism 
of the scientific process and of the results of previous studies, as well as warnings about 
the present study from IEI-EMF advocacy groups (Stop Smart Meters Australia, 2015), 
may have led to many IEI-EMF sufferers being persuaded not to participate. 
Nevertheless, the idiographic nature of the study protocol and the 6 RF-ON and 6 RF-
OFF comparisons were designed to enable the detection of partial IEI-EMF responses 
within each individual case separately. Second, the exposure device used a simulated 
RF signal in the 902-928 MHz ISM band which, although digitally modulated like Wi-
Fi and 3G and 4G signals, would not be typically reported as being the associated 




reserved for industrial, scientific and medical use. The use of simulated signals in 
provocation studies has been criticised (Panagopoulos, Johansson, & Carlo, 2015), 
however, as all 3 participants responded to the active signal in the initial non-blind trial, 
this does not seem to be an issue. Finally, the present study is unable to comment on 
individuals who report more chronic forms of IEI-EMF, as it was unable to assess 
individuals who report more-prolonged symptoms that some IEI-EMF individuals 
report to result from the build-up of exposure from a variety of EMF sources over time 
[Hocking, 1998; Röösli et al., 2004]. 
Despite accounting for a number of possible limitations of IEI-EMF provocation studies 
to date, the results of the case studies presented here fail to demonstrate that the 
symptomatic response of self-reported IEI-EMF participants is affected by EMF 
exposure, nor that they can detect the presence of RF-EMF emissions at greater than 
chance levels. As in other studies, our results also support an alternative hypothesis for 
the aetiology of IEI-EMF; that the symptoms experienced are the result of a nocebo 
response. Indeed the size of resultant r-squared values shows that symptoms are more 
closely related to belief than EMF itself. Given the increasing prevalence of distressing 
and debilitating IEI-EMF symptoms in the general public, there is a great need to better 
understand the triggers for eliciting a harmful EMF nocebo response. Public messaging 
on the EMF topic by scientists and health administrators are no doubt significant 
influences (Wiedemann, Boerner, & Repacholi, 2014; Wiedemann et al., 2013). A 
nocebo aetiology hypothesis also provides useful direction in developing effective 
treatments for people who experience IEI-EMF, whose only current solutions for 
minimizing symptoms involve exposure reduction strategies or the complete avoidance 




financial cost, but they can also have major implications for social and occupational 
functioning. Unfortunately, the ongoing debate over the aetiology of IEI-EMF continues 
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4.  CHAPTER 4: CAN EXPLICIT SUGGESTIONS ABOUT THE 
HARMFULNESS OF EMF EXPOSURE EXACERBATE A 
NOCEBO RESPONSE IN HEALTHY CONTROLS? 
4.1 Chapter Foreword 
Despite accounting for a number of potential methodological limitations, the results of 
the case studies presented in Study 2 (Chapter 3) failed to demonstrate that the 
symptomatic response of self-reported IEI-EMF sufferers is affected by EMF exposure, 
nor that IEI-EMF sufferers could detect the presence of RF-EMF emissions at greater 
than chance levels. In line with previous research, the results also showed that the 
symptoms reported by IEI-EMF sufferers are more closely related to a nocebo response, 
as a significant relationship between a participant’s belief that they were being exposed 
(irrespective of the actual exposure condition) and their symptomatic response was 
observed in each case. As many of the methodological concerns raised by some 
researchers and IEI-EMF sufferers were adequately accounted for in Study 2, these 
results also suggest that the overall lack of evidence for a relationship between EMF 
exposure and symptoms in the extant literature was not a result of potential 
methodological issues.  
While the results of Study 2 provide further support for the psychogenic theory of IEI-
EMF, whether the nocebo response exhibited by IEI-EMF sufferers is specific only to 
IEI-EMF sufferers has not yet been determined. If healthy people were found to exhibit 
a similar response to those who suffer from IEI-EMF during a perceived threatening 
exposure to EMF, this would suggest that the nocebo response exhibited by IEI-EMF 
sufferers may be a normal human response. In addition to this, the factors which 




been some suggestion that alarmist media reports and precautionary information can 
negatively influence people’s beliefs about EMF exposure, whether the negative beliefs 
induced by such information can result in a symptomatic nocebo response following a 
perceived exposure to EMF has not been sufficiently determined. 
The study presented in this chapter (Study 3) investigates whether symptomatic nocebo 
effects can occur in healthy participants, and whether explicit suggestions about the 
adverse effects of EMF can exacerbate a nocebo response. This research will not only 
clarify the role of the nocebo effect in the development of symptoms attributed to EMF, 
but will also examine the factors which may underlie such a response, and will 
determine whether alarmist media reports may contribute to such a response. The 
findings from this study may have important implications for the development of 
effective treatments for IEI-EMF sufferers, as it may help to remove the stigma attached 
to the notion that the condition has a psychogenic origin, which may currently be a 
barrier to seeking treatment. In addition to this, the findings of the current study may 
also help to identify some of the factors which contribute to nocebo responses. This 
chapter has been published in the journal Environmental Research. 
Verrender, A., Loughran, S.P., Dalecki, A., Freudenstein, F., & Croft, R.J. (2018). Can 
explicit suggestions about the harmfulness of EMF exposure exacerbate a nocebo 





4.2  Abstract 
While there has been consistent evidence that symptoms reported by individuals who 
suffer from Idiopathic Environmental Intolerance attributed to Electromagnetic Fields 
(IEI-EMF) are not caused by EMF and are more closely associated with a nocebo effect, 
whether this response is specific to IEI-EMF sufferers and what triggers it, remains 
unclear. The present experiment tested whether perceived EMF exposure could elicit 
symptoms in healthy participants, and whether viewing an ‘alarmist’ video could 
exacerbate a nocebo response. Participants were randomly assigned to watch either an 
alarmist (N = 22) or control video (N = 22) before completing a series of sham and 
active radiofrequency (RF) EMF exposure provocation trials (2 open-label, followed by 
12 randomised, double-blind, counterbalanced trials). Pre- and post-video state anxiety 
and risk perception, as well as belief of exposure and symptom ratings during the open-
label and double-blind provocation trials, were assessed. Symptoms were higher in the 
open-label RF-ON than RF-OFF trial (p < .001). No difference in either symptoms (p = 
.183) or belief of exposure (p = .144) was observed in the double-blind trials. 
Participants who viewed the alarmist video had a significant increase in symptoms (p = 
.041), state anxiety (p <.01) and risk perception (p < .001) relative to the control group. 
These results reveal the crucial role of awareness and belief in the presentation of 
symptoms during perceived exposure to EMF, showing that healthy participants exhibit 
a nocebo response, and that alarmist media reports emphasizing adverse effects of EMF 





4.3  Introduction 
The public’s perception of the potential health implications associated with the use of 
modern technologies has been steadily changing in recent years (Petrie et al., 2001; 
Petrie & Wessely, 2002). This is often reflected in the mainstream media, where news 
reports consistently suggest that there are dangers of various aspects of modern life 
while often neglecting more mundane causes of illness (Frost, Frank, & Maibach, 1997; 
Petrie & Wessely, 2002). Generally, these stories do not reflect the current state of 
science (Claassen, Smid, Woudenberg, & Timmermans, 2012; Eldridge-Thomas & 
Rubin, 2013), but instead focus on reports of members of the community who claim to 
experience conditions characterised by a variety of adverse symptoms which they 
ascribe to their use of, or proximity to, various environmental stimuli, including 
vaccinations, genetically modified food, infrasound from wind turbines and 
electromagnetic fields (EMF) emitted by mobile phone and wireless technologies 
(Petrie & Wessely, 2002).  
One particularly prominent condition is Idiopathic Environmental Intolerance attributed 
to Electromagnetic Fields (IEI-EMF). People who suffer from this condition typically 
report experiencing a diverse range of non-specific symptoms which they attribute to 
their exposure to the EMF emitted by everyday electrical and wireless technologies and 
infrastructure (Baliatsas, Van Kamp, Lebret, & Rubin, 2012; Röösli, Moser, Baldinini, 
Meier, & Braun-Fahrländer, 2004). Yet, while a considerable proportion of the 
population report experiencing IEI-EMF (estimated to be between 1.5 – 13.5% 
(Baliatsas et al., 2015; Blettner et al., 2009; Eltiti, Wallace, Zougkou, et al., 2007; 
Hillert, Berglind, Arnetz, & Bellander, 2002; Levallois, Neutra, Lee, & Hristova, 2002; 




2011)), there has been no robust evidence to implicate a bioelectromagnetic mechanism 
in producing the reported symptoms (Health Canada, 2015; Health Council of the 
Netherlands, 2009; Röösli, Frei, Mohler, & Hug, 2010; Rubin, Das Munshi, & Wessely, 
2005; Rubin, Nieto-Hernandez, & Wessely, 2010; Scientific Committee on Emerging 
and Newly Idenified Health Risks, 2015; Staudenmayer, Binkley, Leznoff, & Phillips, 
2003). For instance, when tested under double-blind protocols, IEI-EMF participants do 
not report an increase in symptoms to EMF and are unable to perceive the difference 
between active and sham exposures (Röösli et al., 2010; Rubin et al., 2010). Instead, the 
evidence suggests that the condition is more closely associated with a nocebo response, 
as awareness of the exposure and a belief of being exposed have been shown to play an 
important role in the presentation of the condition. For example, a number of studies 
have found that participants experience an increase in symptoms when they are aware of 
the active exposure condition in an initial non-blinded trial compared to sham, but do 
not exhibit more symptoms in active than sham exposures in subsequent double-blind 
trials (Eltiti, Wallace, Ridgewell, et al., 2007; van Moorselaar et al., 2017; Verrender et 
al., 2018). Furthermore, sham exposures (i.e. with no EMF) have been shown to be 
sufficient to trigger symptoms in IEI-EMF participants (Nam et al., 2009; Oftedal, 
Straume, Johnsson, & Stovner, 2007; Verrender et al., 2018; Wilén, Johansson, 
Sandström, Kalezic, & Lyskov, 2006). The exact role of the nocebo response in the 
development of IEI-EMF, however, is not fully understood. For instance, recent 
findings from a qualitative study suggest that instead of the condition originating from a 
nocebo response, IEI-EMF individuals may be using the notion of sensitivity to EMF to 
provide a narrative to explain their pre-existing medically unexplained symptoms, in an 
effort to make their condition more practically and emotionally manageable Dieudonné 




participant’s symptoms, but rather, retrospectively asked participants about their beliefs 
regarding the cause of their symptoms. As retrospective self-reports are known to suffer 
from recall bias (Baliatsas et al., 2015; Vrijheid et al., 2009), these methods are not able 
to determine symptom aetiology.  
Given the prevalence of distressing and debilitating IEI-EMF symptoms, and in light of 
the evidence suggesting that such symptoms may be the result of a nocebo response, 
there is a great need to better understand the triggers that elicit such responses. 
Generally, a nocebo response occurs when conscious or subconscious negative 
expectations trigger or exacerbate adverse symptoms in response to an exposure that is 
not known to cause those effects (Bräscher, Kleinböhl, Hölzl, & Becker, 2017; Hahn, 
1997). These expectations may be induced by explicit suggestions about the potential 
effects of an exposure (Benedetti, Lanotte, Lopiano, & Colloca, 2007; Webster, 
Weinman, & Rubin, 2016) or by learning through classical conditioning (Bräscher, 
Kleinböhl, et al., 2017).  
The communication of information about potential adverse health effects associated 
with EMF exposure constitutes an explicit suggestion which may be responsible for the 
formation of negative expectations and consequent nocebo response seen in IEI-EMF 
individuals (Webster et al., 2016). For example, there has been consistent evidence that 
precautionary information can negatively influence beliefs about EMF exposure, despite 
this information originally being intended to reassure the public (Barnett, Timotijevic, 
Shepherd, & Senior, 2007; Nielsen et al., 2010; Wiedemann, Boerner, & Repacholi, 
2014; Wiedemann et al., 2013; Wiedemann & Schütz, 2005; Wiedemann, Thalmann, 
Grutsch, & Schütz, 2006). Similarly, viewing mainstream media reports which either 




EMF, have been shown to increase worries about EMF exposure (Witthöft et al., 2017), 
while viewing an advertisement claiming to protect against the ‘harmful effects of 
everyday EMF exposure’ has been shown to increase both heart rate and concern about 
EMF (Köteles, Tarján, & Berkes, 2016). Further, recent content analyses have shown 
that mainstream media reports about EMF exposure often misrepresent the current state 
of scientific evidence by focusing on an electromagnetic cause for IEI-EMF, or 
suggesting a relationship between EMF exposure and ill-health (Claassen et al., 2012; 
Eldridge-Thomas & Rubin, 2013). If such misinformation is being distributed on a wide 
scale and is negatively influencing people’s beliefs about EMF exposure, it is possible 
that this may be a contributing factor to the prevalence of IEI-EMF. 
Yet, it remains unclear whether the negative beliefs induced by such communications 
can result in greater symptom formation following a perceived exposure to EMF. 
Although Szemerszky, Köteles, Lihi, and Bárdos (2010) demonstrated that suggestions 
about the strength of EMF exposure can lead to increased symptom scores and an 
increase in the belief that a sham magnetic field was active, that study did not assess the 
effect of explicit suggestions of risk from EMF exposure (which may induce negative 
expectations) and was limited by a lack of counterbalancing. Furthermore, while 
Witthöft and Rubin (2013) reported that viewing a sensationalist media report about the 
adverse effects of Wi-Fi can increase the likelihood of a person experiencing symptoms 
following a sham exposure and developing an apparent sensitivity to EMF, the effect 
was only found for those with high pre-existing levels of state anxiety. This may be 
because the study lacked a verified non-exposure condition, potentially resulting in 
insufficient statistical power to detect effects in non-anxious individuals. In support of 




those who watched a film focusing on ‘adverse effects of Wi-Fi’ perceived tactile 
electrical stimuli as more intense during a cued Wi-Fi exposure (which was actually a 
sham exposure) compared to a cued no Wi-Fi condition, and that the effect was not 
mediated by anxiety (Bräscher, Raymaekers, Van den Bergh, & Witthöft, 2017). This 
suggests that manipulating a participant’s belief of exposure via cues may be important 
for influencing symptom perception irrespective of pre-existing state anxiety levels. The 
latter study, however, assessed somatosensory perception rather than symptom 
perception, and so it remains uncertain as to whether negative beliefs induced by 
information about EMF exposure can result in greater symptom formation or belief 
regarding exposure status following a perceived exposure to EMF.   
To address these limitations, the present study was designed to determine whether 
perceived EMF exposure could elicit symptoms in a healthy population, and 
additionally, whether messages emphasizing ‘adverse health effects of EMF exposure’ 
can exacerbate a nocebo response. The study was also designed to explore, within-
subjects, whether there is a relationship between a person’s belief of exposure and 
symptoms, and whether there is a difference in symptom response between participants 
with low, medium and high pre-existing levels of state anxiety. To this end, an initial 
non-blinded open-label trial was employed, where the status of exposures emanating 
from the device (during an active and sham condition) were visually demonstrated to 
each participant using an EMF meter.  
4.4  Materials and Methods 
4.4.1 Participants 
Forty-four participants aged 18 – 30 years (M = 21.92, SD = 4.88; 50% male) were 




Wollongong campus. A power calculation conducted in G*Power 3.0 (Faul, Erdfelder, 
& Buchner, 2007) for an independent samples t test based on an effect size of 0.8, an 
alpha level of .05 and a power of 0.80 recommended a total sample size of 42.  
All participants were first screened via a telephone interview to confirm eligibility for 
the study. To be included in the study, participants were required to be over the age of 
18 and report being of good health. Participants were excluded from the study if they 
reported having a current illness or medical condition, or having used illicit substances 
within the 7-day period prior to the study. Suitable participants were required to attend 
the Illawarra Health and Medical Research Institute for one mutually convenient testing 
session. The study was approved by the Human Research Ethics Committee (HE: 
2016/981). All participants were instructed to abstain from alcohol for at least 8 hr, 
caffeine for at least 1 hr, and mobile phone use for at least 2 hr before the beginning of 
the testing session. Participants were compensated with a monetary gift card for their 
involvement in the study.  
4.4.2 Radiofrequency exposure 
RF exposure was generated using a portable, self-contained, battery-operated device 
(Two Fields Consulting, St Kilda, Australia). The RF device was placed 30 cm to the 
left side of the participant (at approximately shoulder to head height) on a hard surface. 
The main exposure from the device was a spread spectrum RF signal in the 902-928 
MHz ISM band which was digitally modulated in a similar manner to signals from Wi-
Fi and 3G/4G mobile phones. The RF signal was generated by a commercial RF modem 
which emitted a frequency hopping spread spectrum signal with an average radiated 
power output of 1 W for 10 min (RF-ON), or was completely EMF silent (RF-OFF, 




participant was measured using a calibrated broadband instrument with an uncertainty 
of ± 2.4 dB for a two-sided coverage interval and a coverage factor of 2 (Narda EMR 
300 meter and Type 9 E-field probe, Narda Safety Test Solutions, Hauppauge, NY), and 
was found to be 0.3 W/m². This RF exposure level is below the power density reference 
level limit of 4.6 W/m² specified for the Australian general public (ARPANSA RPS3) 
and by the International Commission on Non-Ionizing Radiation Protection (ICNIRP, 
1998). It is important to note that the maximum localised specific absorption rate (SAR) 
from the exposure device used in the present study is less than that induced from 
personal mobile phone use (held against the ear in the active talk mode) due to the 
greater separation distance. Conversely, the whole body averaged SAR and localised 
SAR of the device are greater than those normally produced by Wi-Fi and mobile phone 
base station signals. The device was fully enclosed in a thermally insulated case and 
coded inputs were used to maintain double-blinding. The device contained an 
independent RF monitor to check the status of the RF transmitter and each use of the 
device was logged using internal memory.  
4.4.3 Questionnaires 
4.4.3.1 Symptoms and exposure status scale (SESS) 
During the provocation trials, participants were asked to indicate whether they believed 
the exposure was on or off, and to rate whether they were experiencing any symptoms 
via pen and paper 100 mm visual analogue scales. To assess belief of exposure, 
participants were asked “how sure are you of the current exposure status right now?” 
anchored with the terms ‘Definitely OFF’ and ‘Definitely ON’. To assess symptom 
experience, a modified state version of the 34 item Checklist for Symptoms in Daily 




asked “how strong/unpleasant are the following symptoms right now?” anchored with 
the terms ‘Barely Detectable’ and ‘Maximum Severity’. These response categories 
differed from the original questionnaire (Wientjes & Grossman, 1994) and were used in 
line with our previous study (Verrender et al., 2018). The symptom responses of the 34 
items were added to calculate a total symptom score for each of the baseline and 
exposure intervals in each trial. The primary dependent variables for belief of exposure 
and symptoms in the provocation trials were calculated as difference scores between the 
baseline and exposure questionnaires (exposure interval minus preceding baseline) 
given during each trial (see procedure below); a difference score was used to minimise 
the influence of baseline variability and potential carry-over effects. 
4.4.3.2 Risk perception questionnaire (RPQ) 
A self-generated risk perception questionnaire comprising 4 questions was used to 
assess EMF risk perception. Question 1 assessed concerns about electromagnetic fields 
in general and question 2 assessed concerns about electromagnetic fields in relation to 
mobile phones and Wi-Fi. Participants were asked “How concerned are you about the 
potential health risks of electromagnetic fields in general?” rated on a 7-point Likert 
scale (1 = not worried at all, 7 = very worried) and “All in all, how threatened do you 
feel by electromagnetic radiation emissions from mobile phones and Wi-Fi?” rated on a 
7-point Likert scale (1 = not threatening at all, 7 = very threatening). To enable 
standardised measurement of RF-EMF risk perception in relation to mobile phones and 
Wi-Fi, questions 3 and 4 used picture-guided scenarios which illustrated everyday 
exposure situations (Freudenstein, Wiedemann, & Brown, 2015). Participants were 
asked “How dangerous do you think the electromagnetic fields from mobile phones are 




think the electromagnetic fields are from Wi-Fi routers in close proximity, as illustrated 
in this picture?” rated on a 7-point Likert scale (1 = not dangerous at all, 7 = very 
dangerous). The RPQ score was defined as the mean score from all responses. 
4.4.3.3 State and Trait Anxiety Index (STAI) 
The 40 item version of the STAI (Spielberger, Gorsuch, & Lushene, 1970) was used to 
assess participant’s state and trait anxiety. This comprises two, 20-item forms, assessing 
state (STAI-Y1) and trait (STAI-Y2) anxiety separately, with items answered on a 4-
point Likert scale (1 = not at all, 4 = very much so). Low, medium and high anxiety 
were defined as being less than minus 1 standard deviation from the mean, between 
minus 1 standard deviation and plus 1 standard deviation from the mean, and greater 
than plus 1 standard deviation from the mean, respectively (Witthöft & Rubin, 2013). 
4.4.3.4 NEO Five Factor Personality Index (NEO-FFI) 
The 60 item NEO-FFI (Costa & McCrae, 1992) was used to assess personality traits: 
Extraversion, Agreeableness, Conscientiousness, Neuroticism, and Openness to 
Experience. This measure is beyond the scope of this paper and will not be discussed 
further. 
4.4.4 Design 
In an experimental between-groups design, participants were assigned to the alarmist or 
control video group by a computerised random allocation process. In the alarmist video 
group, participants viewed a 3 min video appeal to the United Nations from a concerned 
scientist asking that more precautionary action be taken in regard to EMF exposure 
“from our favourite gadgets.” This included statements about the potential health risks 




scenarios (Blank, 2015). In the control group, participants viewed a 3 min segment of a 
documentary on gravity (Cox, 2013). This video contained no health related content. To 
minimise the influence of experimenter bias, a researcher not involved in data collection 
(AD) was responsible for the randomisation and administration of the videos. 
For the provocation trials, a randomised, counterbalanced, cross-over design was 
employed. Each participant’s symptoms and belief of exposure was tested under a series 
of 14 sham and active provocation trials. The first two trials were non-blinded, open-
label trials (1 RF-OFF, 1 RF-ON), where both the participant and the researcher were 
aware of the exposure status. This was verified to the participant using a Nardalert S3 
broadband monitor (Narda Safety Test Solutions, Hauppauge, NY). These trials were 
followed by a series of 12 double-blind, randomised, counterbalanced trials (6 sham, 6 
RF-ON). Randomization and counterbalancing was achieved using Excel 
(randomization command), such that a sham and RF-ON condition were treated as a 
pair; the conditions for each pair were randomly allocated before assigning the next 
pair; and no more than three of the same pair-order were permitted.  
4.4.5 Procedure 
A participant information sheet was sent to people who responded to recruitment flyers. 
This informed participants that a small percentage of the population report being 
sensitive to EMF, described some of the symptoms reported by IEI-EMF sufferers and 
explained that although the scientific evidence has yet to establish a clear relationship 
between exposure and symptoms, news reports about the possible adverse health effects 
of RF exposure continue to focus on people who report these symptoms. The general 




Following a telephone screening interview, suitable participants were booked in for one 
mutually convenient testing session starting at 09:00 am, which lasted approximately 
5.5 hr. Upon arrival at the laboratory, participants provided informed written consent 
and were given a verbal briefing of the ensuing testing session. After being instructed to 
switch off and leave all electronic devices in a general area of the laboratory, 
participants were then seated comfortably inside a Faraday cage, where they completed 
the baseline (Time 1 (T1)) measures of the STAI and RPQ. After completing the T1 
questionnaires, participants then watched one of the two videos (based on their 
randomly assigned group). To maximise attention, participants were instructed to pay 
attention to the video as they would be required to answer questions about the video as 
part of a memory test at the conclusion of the study (although no memory test was 
conducted). After watching the video, participants again completed the STAI and RPQ 
(Time 2 (T2)). The exposure device was then set up and the provocation trials 
commenced, beginning with the initial 2 open-label trials (1 RF-OFF, 1 RF-ON), 
followed by the 12 double-blind trials. Each of the provocation trials lasted 20 min, 
beginning with a 5 min baseline interval, followed by a 10 min exposure interval (RF-
ON or RF-OFF/sham, depending on randomization and counterbalancing), and 
concluded with a 5 min rest interval before the onset of the next trial. In each trial, 
participants were required to complete the SESS 2.5 min into the baseline interval and 
again 7 min into the exposure interval. At the conclusion of the provocation trials, 
participants were led out of the Faraday cage and asked whether they had any questions 
or concerns about any aspect of the experiment. No participants reported any concern 




4.4.6 Statistical analyses 
Statistical analyses were performed with SPSS Statistics for Windows, Version 23.0 
(IBM, Armonk, New York). Where normality tests and visual inspection of the data 
revealed violations to the assumption of normality, non-parametric tests were employed 
and the corresponding effect sizes (ES) were calculated as r, (where 0.1 = small, 0.3 = 
medium and 0.5 = large (Cohen, 1988)). Where parametric tests were conducted, 
corresponding effect sizes were calculated as Cohen’s d, (where 0.3 = small, 0.5 = 
medium and 0.8 = large (Cohen, 1988)). 
4.4.6.1 Preliminary Analyses:   
Independent samples t tests were used to compare pre-existing (T1) levels of state 
anxiety (STAI-Y1), trait anxiety (STAI-Y2) and risk perception (RPQ) between the 
control and alarmist video groups. A Wilcoxon Signed-Ranks test was used to 
determine whether participants understood the exposure protocol by assessing whether 
there was a difference in belief of exposure rating of the SESS between the RF-OFF and 
RF-ON open-label trials.  
4.4.6.2 Hypothesis Driven Analyses:  
A Wilcoxon Signed-Ranks test was used to determine whether there was a main effect 
of exposure on the symptom score of the SESS in the open-label trials. To assess 
whether there was an interaction between video group and symptom score, a symptom 
difference score (RF-ON minus RF-OFF) was calculated and a Mann-Whitney U test 
used to compare the difference score between control and alarmist video groups in the 





4.4.6.3 Exploratory Analyses:  
To verify whether there was no effect of RF-EMF exposure, Wilcoxon Signed-Ranks 
tests were used to determine whether there was a main effect of exposure on either the 
belief of exposure rating or the symptom score of the SESS in the double-blind trials. 
To assess whether there was an interaction between video group and either belief of 
exposure rating or symptom score, a difference score for each variable was calculated 
(RF-ON minus RF-OFF). These difference scores were calculated by averaging the 
belief of exposure, and separately the symptom difference scores (already calculated as 
the difference between the baseline and exposure intervals) of each variable across the 6 
RF-ON and 6 RF-OFF conditions. The averaged RF-ON score was then subtracted from 
the averaged RF-OFF score. Mann-Whitney U tests were then used to compare each of 
these variables between the control and alarmist video groups.  
Spearman’s rho measure of association was used to test whether there was a relationship 
between belief of exposure and symptoms in the double-blind trials (irrespective of 
actual exposure condition) for each individual participant. The resultant rho values were 
then transformed using a Fisher transformation, and a one sample t test was used to 
determine whether these transformed correlations differed from 0. An independent 
samples t test was used to assess whether there was a difference in the Fisher 
transformed Spearman’s rho values between the control and alarmist video groups. 
Mann-Whitney U tests were used to assess whether the difference between T1 and T2 
STAI-Y1 score, and separately RPQ score, differed between the control and alarmist 




A Jonckheere-Terpstra test was used to determine whether there was a linear trend in 
the symptom score of the RF-ON open-label trial as a function of pre-existing state 
anxiety.   
4.5  Results 
4.5.1 Preliminary Analyses 
The means, standard deviations and test statistics for assessing whether there were 
significant differences between the control and alarmist video groups in relation to pre-
existing levels of state anxiety (STAI Y-1), trait anxiety (STAI – Y2) and risk 
perception (RPQ) are displayed in Table 4.1. No significant differences were detected. 
Verifying that participants understood the exposure protocol (they believed that they 
were being exposed in the open-label RF-ON condition and that they were not being 
exposed in the open-label RF-OFF condition), belief of exposure ratings were 
significantly higher in the RF-ON (Median = 100) compared to the RF-OFF (Median = 
0) condition, T = 0.00, z = - 5.86 (corrected for ties), N – ties = 44, p < .001, ES = 0.88. 
All participants correctly reported that they were confident that the exposure was 
‘Definitely ON’ in the RF-ON condition and ‘Definitely OFF’ in the RF-OFF condition 









Table 4.1: Descriptive statistics and tests for differences in pre-existing levels of state 
anxiety, trait anxiety and risk perception between the two video groups.  
M = mean; SD = standard deviation; ES = effect size. 
4.5.2 Hypothesis Driven Analyses: 
4.5.2.1 Symptoms in the open-label trials: 
Figure 4.1 shows the SESS symptom scores for the RF-OFF and RF-ON open-label 
trials. Overall, participants had significantly higher increases in symptom scores in the 
RF-ON condition (Median = 17.00) compared to the RF-OFF condition (Median = -
0.50), T = 77.00, z = -4.476 (corrected for ties), N - ties = 40, p < .001, ES = 0.71.  
4.5.2.2 Effect of video group on symptoms in the open-label trials: 
The symptom scores in the RF-OFF condition were equal between the alarmist (Mean = 
11.59 Median = -3) and control (Mean = 11.45 Median = 0) video groups, validating the 
comparison of symptom difference scores between the two groups. Figure 4.2 shows the 




N = 22 
Alarmist video 
N = 22 
Test statistic for 
differences between 
groups 
State Anxiety M = 29.00, SD = 8.11 
M = 30.45, SD = 
9.96 
t(42) = -0.639,  
p = .527, ES = 0.19 
Trait Anxiety 
M = 38.45, SD = 
11.85 
M = 36.41, SD = 
9.79 
t(42) = -0.624,  
p = .536, ES = 0.19 
Risk Perception M = 2.35, SD = 1.12 M = 2.51, SD = 1.09 
t(42) = - 0.477,  




in the open-label trials. The symptom difference score was higher in the alarmist 
(Median = 25.50) compared to the control (Median = 5.00) video group, and the 
interaction between symptom difference score and video group was significant, U = 
159.50, z = -1.738, p = .041 (one-tailed), ES = 0.263. 
  
                                                     
3 One significant outlier was removed from this analysis. The interaction between symptom difference 
score and video group only reached trend level when including this outlier, U = 181.50, z = -1.421, p = 






















































Figure 4.1 The mean (dot), median (line), interquartile range (box) and range 
(whiskers) of the SESS symptom scores are shown for the RF-OFF and RF-ON open-
label trials. 
Figure 4.2: The mean (dot), median (line), interquartile range (box) and range (whiskers) of 
the difference in SESS symptom score (RF-ON – RF-OFF) are shown as a function of video 




4.5.3 Exploratory Analyses 
4.5.3.1 Effect of exposure on belief of exposure and symptoms in the double-blind trials: 
The SESS belief of exposure ratings in the RF-ON and sham double-blind trials are 
shown in Figure 4.3. Overall, there was no difference in belief of exposure rating 
between the RF-ON (Median = 34.58) and sham conditions (Median = 38.33), T = 
331.00, z = -1.062 (corrected for ties), N – ties = 40, p = .144 (one-tailed), ES = 0.17, 
indicating that there was no main effect of exposure on belief of exposure rating. Three 
participants correctly identified at greater than chance levels (within-subjects), when 
they were and were not being exposed in the double-blind trials, with 1 participant 
getting 75% correct and 2 participants getting 83% correct. No other participants could 
correctly identify when they were being exposed. Given a chance level of 5% and that 
there were 44 participants, it would be expected that 2.2 participants would correctly 
identify the conditions by chance. 
The SESS symptom scores in the RF-ON and sham double-blind trials are shown in 
Figure 4.4. Overall, there was no difference in symptom score between the RF-ON 
(Median = 10.33) and sham conditions (Median = 10.33), T = 398.00, z = -0.906 
(corrected for ties), N – ties = 43, p = .183 (one-tailed), ES = 0.14, indicating that there 
was no main effect of exposure on symptoms.  
Spearman’s rho measure of association showed that the relationships between belief of 
exposure and symptoms in the double-blind trials were highly variable between 
participants. These values ranged from -.276 to .882 in the control video group and -
.675 to .852 in the alarmist video group. Following a Fisher transformation, a one-
sample t test found that the transformed rho values were significantly greater than 0, 




4.5.3.2 Effect of video group on belief of exposure and symptoms in the double-blind 
trials: 
The belief of exposure difference score (RF-ON – Sham) also not differ between the 
control (Median = -0.33) and alarmist (Median = 4.25) video groups, U = 186.50, z = -
1.303, p = .096 (one-tailed), ES = 0.20, indicating that there was no interaction between 
video group and belief of exposure rating. The symptom difference score (RF-ON – 
Sham) also did not differ between the control (Median = -1.25) and alarmist (Median = 
1.92) video groups, U = 218.00, z = -0.563, p = .287 (one-tailed), ES = 0.08, indicating 
that there was no interaction between video group and symptoms. 
4.5.3.3 Effect of video on state anxiety and risk perception:  
The difference in state anxiety (STAI-Y1) from T1 to T2 was significantly higher in the 
alarmist (Median = 3.50) compared to the control (Median = -.50) video group, U = 
135.50, z = -2.505, p <.01 (one-tailed), ES = 0.38. The difference in risk perception 
(RPQ) from T1 to T2 was also significantly higher in the alarmist (Median = 1.00) 
compared to the control (Median = 0.00) video group, U = 75.50, z = -3.946, p < .001 
(one-tailed), ES = 0.60.  
4.5.3.4 Relationship between belief of exposure and symptoms in double-blind trials as 
a function of video group: 
The relationship between belief of exposure and symptoms (Fisher transformed 
Spearman’s rho values) did not differ between the control (M = .47, SD = .48) and 




4.5.3.5 Relationship between pre-existing state anxiety and symptoms in open-label 
trials: 
Figure 4.5 shows the SESS symptom scores as a function of anxiety group. No 
significant trend between symptom scores and higher levels of pre-existing anxiety was 






























Figure 4.3: The mean (dot), median (line), interquartile range (box) and range (whiskers) of 
the SESS belief of exposure rating are shown for the sham and RF-ON double-blind trials. 
Figure 4.4: The mean (dot), median (line), interquartile range (box) and range 

























Figure 4.5: The mean (dot), median (line), interquartile range (box) and range (whiskers) of 
the SESS symptom scores in the RF-ON open-label trial are shown as a function of pre-



































4.6  Discussion 
While there has been growing evidence that the symptoms reported by IEI-EMF 
sufferers are likely the result of a nocebo effect (Eltiti, Wallace, Ridgewell, et al., 2007; 
Nam et al., 2009; Oftedal et al., 2007; van Moorselaar et al., 2017; Verrender et al., 
2018; Wilén et al., 2006), there has been limited understanding of the factors which 
contribute to such a response. Although a number of studies have shown that explicit 
suggestions about the adverse effects of EMF exposure can increase concern and 
negatively influence people’s beliefs about EMF exposure (Barnett et al., 2007; Köteles 
et al., 2016; Nielsen et al., 2010; Wiedemann et al., 2014; Wiedemann et al., 2013; 
Wiedemann & Schütz, 2005; Wiedemann et al., 2006; Witthöft et al., 2017) (factors 
which are considered to be key in contributing to a nocebo response (Webster et al., 
2016)), it has remained relatively unclear whether the negative beliefs induced by such 
communications can result in greater symptom formation following a perceived 
exposure to EMF. The purpose of this experiment was to investigate whether perceived 
EMF exposure would elicit symptoms in a healthy population and to assess whether 
messages that emphasise ‘adverse health effects of EMF exposure’ can induce a nocebo 
response, including for those without high pre-existing levels of state anxiety. In the 
provocation trials, both active and sham EMF exposures were first demonstrated to 
participants in an initial non-blinded, open-label trial, before a series of double-blind, 
randomised, counterbalanced trials were conducted. By demonstrating that the 
experiment contained a ‘no exposure’ condition, the present study was able to more 





A number of preliminary tests were first used to establish whether the experiment was 
valid and whether the experimental manipulation had worked. These checks 
demonstrated that there were no differences in pre-existing levels of state anxiety, trait 
anxiety and EMF risk perception between the alarmist and control video groups. 
Further, these tests verified that participants understood the exposure protocol, as they 
correctly indicated that they were being exposed in the RF-ON open-label trial and not 
being exposed in the RF-OFF open-label trial.  
The results of the provocation trials revealed the crucial role of awareness and belief in 
the presentation of symptoms during perceived exposure to EMF. In the open-label 
trials, participants reported higher symptom scores in the RF-ON trial compared to the 
RF-OFF trial. In the subsequent double-blind trials, however, there was no difference in 
either belief of exposure or symptom scores between the RF-ON and sham conditions. 
These findings demonstrate that knowledge and/or awareness of the exposure condition 
was essential for producing an effect on symptoms. In addition to this, belief of 
exposure was found to be positively associated with higher symptom scores in the 
double-blind trials, giving further indication that a nocebo effect, rather than EMF 
exposure itself, was responsible for the increase in symptoms. In regards to the effect of 
messages which emphasise the ‘adverse health effects of EMF exposure’, the present 
study found that participants who viewed the alarmist video had higher symptom scores 
in the open-label trials than participants who viewed the control video. While, in 
contrast to Witthöft and Rubin (2013), the present study found that the effect of the 
video on symptom score was not moderated by pre-existing levels of state anxiety, it is 
important to note that the effect of the video on symptom score in the present study was 




effect of the video was strongly influenced by the individuals in the study. This 
corresponds to the notion that both situational factors (such as viewing a particular 
media report) and dispositional factors (such as personality traits) interact to influence 
people’s worries about the potential health hazards of modern life, though further 
research is required to clarify the personality traits which may be involved in 
moderating this effect (Witthöft et al., 2017). It is important to note, however, that 
sample size may also play a considerable role in the interaction between the type of 
video viewed and symptom score, and a larger sample size would have increased the 
chance of identifying an effect of the video in the present study. In line with previous 
research, the present study also found that participants who viewed the alarmist video 
had a larger increase in state anxiety and risk perception from baseline relative to those 
who viewed the control video (Bräscher, Raymaekers, et al., 2017; Witthöft et al., 2017; 
Witthöft & Rubin, 2013). This provides further support to the notion that 
sensationalised media reports are capable of increasing people’s concerns and worries 
about exposure to EMF. Nonetheless, it is also possible that pre-existing beliefs about 
the relative harmfulness of EMF exposure may have influenced the results of this study 
via a ceiling effect. Future studies could usefully address this issue by using pre-
screening to allocate participants into “high” and “low” risk perception groups, within 
each of the control and alarmist video groups. 
Overall, the results of the present study corroborate those of IEI-EMF provocation 
studies, and demonstrate that the belief of being exposed, rather than EMF exposure 
itself, is sufficient to trigger symptoms in healthy participants, including those without 
high pre-existing levels of anxiety. This is supported by the fact that 77% of participants 




while no difference in symptom score was detected in the double-blind trials. Although 
the size of the effect on symptoms in the open-label trials in the present study was not as 
large as the effect observed for IEI-EMF sufferers in a previous study (ES > 3.6) 
(Verrender et al., 2018), the effect observed in the present study was still quite large (ES 
= 0.71), and is larger than the traditionally used nomenclature of Cohen (1988) (who 
treats the largest category of effect size as >.05). This may indicate that the nocebo 
response displayed by IEI-EMF sufferers during a perceived exposure situation is a 
normal human response. In addition to this, the results of the present study not only 
support those of previous studies suggesting that sensationalist media reports about 
perceived environmental hazards can raise concerns and negative beliefs about EMF, 
but also demonstrate that such reports may be contributing to a symptomatic nocebo 
response. This is analogous to the conclusions reached by studies investigating whether 
media health warnings can influence symptom expectations after exposure to infrasound 
from wind turbines or chemical pollution (Crichton, Dodd, Schmid, Gamble, & Petrie, 
2014; Winters et al., 2003) and further emphasises the importance of disseminating 
accurate scientific and health information in order to reduce the likelihood of 
symptomatic nocebo responses in the community more generally.  
A number of potential limitations should be considered when interpreting the results of 
the present study. First, as the sample was mainly comprised of a relatively young 
healthy population, the present study is unable to comment on whether similar effects of 
alarmist media would be observed in a more general population sample. While online 
advertisements were used in an attempt to attract greater interest in the study, future 
studies could address this issue by using local newspapers and radio stations to recruit 




the RF-ON condition in the open-label trials, the possibility that part of the increase in 
symptoms in the open-label trials (independent of the media content) was due to the 
elapsed study time cannot be completely ruled out. However, it is important to note that 
participants in provocation studies generally do not report such large increases in 
symptoms as a function of time (Schmidt, Wolfs-Takens, Oosterlaan, & van den Hout, 
1994). In addition to this, it is possible that effects on risk perception and symptoms 
may be triggered by any message on EMF and health, irrespective of whether it is an 
alarmist or positive message. However, Crichton and Petrie (2015a) found that 
positively framed health information may reverse or dilute the effect of negative 
expectations formed by alarmist media in the context of infrasound exposure, which 
suggests that the frame of the message is important for symptom perceptions. 
Nevertheless, future studies could include a third ‘positive’ video group to address this 
issue. Finally, due to feasibility requirements, the present study was limited to assessing 
acute symptom responses to acute exposures and the experiment was conducted in a 
laboratory setting using a Faraday cage. It is important that these factors are taken into 
consideration when interpreting the results of the present study, as these conditions may 
not reflect typical everyday exposure scenarios.   
Although the present study has provided further evidence that symptoms attributed to 
EMF exposure are likely the result of a nocebo response, one of the major difficulties in 
treating IEI-EMF is the stigma attached to the notion that the condition is a 
psychological illness. While cognitive-behavioural therapy has been shown to be 
efficacious in treating IEI-EMF (Rubin, Das Munshi, & Wessely, 2006), simply telling 
sufferers that their symptoms do not have a toxicological cause is not reassuring and is 
unlikely to completely alleviate symptoms (Rief, Heitmüller, Reisberg, & Rüddel, 




individual feedback on the results of double-blind provocation studies reduced IEI-EMF 
participants certainty about responding to acute EMF exposures, the feedback did not 
materially change IEI-EMF sufferers perception of being sensitive to EMF in their 
everyday life. Likewise, Nieto-Hernandez, Rubin, Cleare, Weinman, and Wessely 
(2008) found that providing feedback to IEI-EMF sufferers about their ability to 
discriminate between active and sham exposures had no influence on subsequent 
symptom levels or perceived sensitivity to EMF. Explaining the nocebo response may, 
however, offer an alternative solution. Recently, Crichton and Petrie (2015b) found that 
participants who reported symptomatic experiences during infrasound exposure returned 
mood and symptom levels to baseline levels in a subsequent exposure after they had 
received an explanation of the nocebo response with supporting scientific evidence. 
Whether such an effect could be replicated in people who experience IEI-EMF, 
however, remains unclear. Explaining that the nocebo response experienced by IEI-
EMF sufferers is a normal human response may also offer a useful approach for 
addressing the condition in the future. Nonetheless, it is conceivable that explaining 
psychological mechanisms to people who claim to experience IEI-EMF may be 
interpreted as offensive or lacking credibility. It may thus be more appropriate (and 
more accurate) to emphasise that although EMF has not been shown to cause 
symptoms, that this does not mean that IEI-EMF symptoms are necessarily due to the 
nocebo effect; they may also relate to an undiagnosed medical condition (Dieudonné, 
2016) which would require attention from a medical professional. Discussing the 
potential aetiology of symptoms with IEI-EMF sufferers is thus a difficult task, and one 
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5. CHAPTER 5: GENERAL DISCUSSION 
Despite decades of research, the aetiology of IEI-EMF has remained extremely 
controversial. While much of the existing literature has not found convincing evidence 
of a relationship between EMF exposure and the symptoms reported by IEI-EMF 
sufferers (Röösli, Frei, Mohler, & Hug, 2010; Rubin, Nieto-Hernandez, & Wessely, 
2010), it has been estimated that between 1.5 – 13.3% of the population report 
experiencing the condition. While disagreement has existed over the cause of IEI-EMF, 
it has generally been agreed that sufferers are experiencing real symptoms which 
significantly impair their daily functioning and quality of life (Johansson, Nordin, 
Heiden, & Sandström, 2010; Rubin, Hillert, Nieto-Hernandez, van Rongen, & Oftedal, 
2011). The continuing aetiological debate, however, has limited the development of 
effective treatments and support for those who experience the condition, and this has 
warranted the need for further investigation. 
The overall aim of the present doctoral research was to clarify the determinants of IEI-
EMF by investigating whether toxicogenic or psychogenic processes can explain the 
symptoms reported by IEI-EMF sufferers. Specifically, the research contained in this 
thesis encompassed three human provocation studies, each designed with considerable 
methodological improvements on the extant literature, to determine whether individuals 
can be sensitive to EMF exposure and to further explore the potential role of 
psychological processes and alarmist media reports in the presentation of symptoms 
attributed to EMF exposure. The following chapter discusses the findings and 
contribution of each study to the literature, and outlines the implications of this research 




The potential limitations of this research are also discussed, and directions for future 
studies are highlighted.  
5.1  Contribution to the Literature 
5.1.1  No evidence of an adverse functional consequence of RF-EMF  
A number of studies have consistently shown that exposure to RF-EMF, similar to that 
emitted by a mobile phone, can influence the brain’s electrical activity, specifically in 
the spontaneous resting alpha (Croft et al., 2008; Croft et al., 2010; Curcio et al., 2005; 
Leung et al., 2011; Perentos, Croft, McKenzie, Cvetkovic, & Cosic, 2007; Regel, 
Gottselig, et al., 2007) and sleep spindle (Huber et al., 2000; Huber et al., 2002; 
Loughran et al., 2005; Regel, Tinguely, et al., 2007; Schmid et al., 2012) frequencies of 
the electroencephalogram (EEG). Given the close relationship between the EEG and 
cognition, and given that IEI-EMF sufferers often report memory and concentration 
difficulties as symptoms which they attribute to EMF exposure, Study 1 (Chapter 2, 
Verrender, Loughran, Dalecki, McKenzie, & Croft, 2016) was developed as a means of 
establishing whether exposure to RF-EMF below the established safety guidelines is 
capable of eliciting these effects in humans. While a number studies assessing various 
aspects of cognitive and behavioural functioning have found inconsistent, but mostly 
null results (Barth, Ponocny, Gnambs, & Winker, 2012; Barth et al., 2008; Valentini, 
Ferrara, Presaghi, De Gennaro, & Curcio, 2010), the methodological issues inherent in 
previous research may have limited the ability of these studies to detect real effects. If 
clear adverse effects on cognitive performance could be demonstrated in healthy 
participants, this could offer a starting point for determining the most sensitive 
endpoints with which to test IEI-EMF participants. Thus, to address the potential 




objective test for IEI-EMF sufferers, Study 1 was designed with considerable 
methodological improvements to determine whether RF-EMF exposure could influence 
cognitive performance in a dose-dependent manner. 
The first stage of Study 1 required identifying possible methodological constraints in 
previous studies and developing appropriate improvements to overcome these issues. 
For instance, previous studies have generally relied on cognitive performance measures, 
such as the N-back task, because of their perceived face validity or as a means to 
replicate previously reported effects. However, these measures have generally been 
unable to account for individual variation in cognitive performance (Regel & 
Achermann, 2011), or have been found to be affected by learning effects (Haarala et al., 
2005; Haarala et al., 2004; Regel, Gottselig, et al., 2007; Regel, Tinguely, et al., 2007). 
This means that the cognitive performance tasks utilised in previous studies have not 
been able to reliably measure the potential effects of RF-EMF exposure on cognition 
due to large error variance (Regel & Achermann, 2011). To overcome this issue, the 
cognitive performance tasks utilised in Study 1 were individually calibrated to each 
participant’s cognitive ability, and sufficiently long practice blocks were conducted 
before each experimental session to reduce the influence of potential learning effects. In 
addition to this, Type I and Type II error was minimised by treating the data using an 
index of the participants’ response sensitivity and bias, as adapted from signal detection 
theory (Stanislaw & Todorov, 1999). This treatment takes into account how well a 
participant can discriminate between trials (sensitivity) and the participant’s general 
tendency to respond with a ‘yes’ or ‘no’ button press (bias), giving a better indication of 
task performance. Further to these improvements on the cognitive performance tasks, 




temperature to a thermo-neutral state. This is potentially important, because it is 
possible that whole body thermoregulatory processes play an integral role in mediating 
the changes in the brain’s electrical activity and any functional effects resulting from 
exposure to RF-EMF given that the primary mechanism of interaction between RF and 
the human body is thermal (Adair & Black, 2003). Together, the improvements 
implemented in Study 1 were intended to increase the sensitivity of the experiment, and 
thus the ability to detect potential effects. 
The results of Study 1 indicated that exposure to pulse modulated RF-EMF, similar to 
that emitted by a mobile phone, may influence cognitive performance. Specifically, a 
small improvement in reaction time was observed on the Sternberg working memory 
task during exposure compared to sham. The improvement in performance, however, 
was not found to be dose dependent, and the relatively small effect size means that it 
may not be important in relation to normal variation in cognitive performance. While a 
number of studies have not found that pulse modulated RF-EMF influences behavioural 
measures of cognitive performance (Haarala et al., 2003; Haarala et al., 2004; Haarala et 
al., 2007; Krause, Pesonen, Bjornberg, & Hamalainen, 2007; Leung et al., 2011), the 
methodological improvements employed in Study 1 may have increased the sensitivity 
of the experiment and thus enhanced the ability to detect potential effects. However, 
without further replication, it is unclear whether the improvement in performance 
observed in Study 1 represents more than a chance finding. Consequently, despite 
accounting for a number of methodological limitations, Study 1 did not provide 
sufficiently convincing evidence that exposure to RF-EMF can influence cognitive 
performance; it thus did not identify any sensitive cognitive performance endpoints with 




5.1.2  No evidence of a relationship between IEI-EMF symptoms and EMF 
exposure 
As Study 1 did not identify an appropriate objective cognitive performance measure 
with which to test IEI-EMF participants, and indeed, did not find convincing evidence 
that exposure to RF-EMF can elicit adverse functional effects on cognitive performance, 
Study 2 (Chapter 3, Verrender, Loughran, Anderson, et al., 2018) was designed as a 
series of individual case studies to test whether exposure to RF-EMF results in an 
increase in IEI-EMF participants self-nominated symptoms compared to sham, and 
additionally, to determine whether IEI-EMF individuals could accurately detect the 
presence of EMF emissions under double-blind conditions. Despite much of the existing 
literature indicating that the symptoms experienced by IEI-EMF sufferers are the result 
of a nocebo effect (Röösli et al., 2010; Rubin et al., 2010), some researchers and many 
IEI-EMF sufferers have raised concerns about the way in which IEI-EMF provocation 
studies have been conducted and have argued that methodological issues have 
influenced the results of previous studies (Leszcynski, 2018; Weller, 2014). These 
concerns have often been related to questions about whether laboratory testing 
environments adequately reflect the conditions in which symptoms are normally 
developed, and worries about whether previous studies have adequately accounted for 
the heterogeneous nature of IEI-EMF (including between-subject differences in both 
symptoms and EMF triggers).  
To address these concerns, Study 2 incorporated a number of important methodological 
improvements. First, to reduce the stress and anxiety experienced by participants in a 
laboratory experiment, and to minimise potential confounding effects associated with 




portable exposure device which enabled double-blind testing to take place in 
environments where participants generally felt safe and asymptomatic, such as in their 
own home. Second, to limit potential statistical confounds, the study took an 
idiographic, case-study approach to testing, and used a sufficient number of sham and 
active exposure trials to determine statistically, within each participant, whether any 
symptom/exposure relationship was significant. Further to this, the study included a 
consideration of each participants IEI-EMF history, which involved using a similar RF-
EMF exposure to the one which the participant claimed triggers symptoms as well as 
verifying that the exposure triggered symptoms in an open-label trial. In addition, the 
testing protocol could be modified, if necessary, to match the reported symptom onset 
and recovery periods for each participant, thus accounting for potential inter-individual 
heterogeneity in symptom onset and recovery times. Finally, the design incorporated a 
fully counter-balanced protocol in order to reduce time of day and time on task effects. 
Yet, despite accounting for a number of potential limitations of previous IEI-EMF 
provocation studies, the results of the case studies presented in Study 2 failed to 
demonstrate that the symptomatic response of self-reported IEI-EMF sufferers is 
affected by EMF exposure, nor that IEI-EMF sufferers could detect the presence of RF-
EMF emissions at greater than chance levels. While all three case study participants 
displayed an increased symptom severity and were confident that they could detect the 
presence of RF-EMF in the RF-ON compared to RF-OFF open-label trial, no significant 
differences in symptom severity or exposure detection were found between the RF-ON 
and sham conditions in the double-blind trials. Notably, in each case, a significant 
relationship between a participant’s belief that they were being exposed (irrespective of 




strong indication the symptoms experienced were more closely related to a nocebo 
response. In line with the overall pattern of results of previous provocation studies 
investigating IEI-EMF (Rubin et al., 2010), these findings confirm that awareness 
and/or belief of exposure status, rather than the EMF exposure itself, is more closely 
associated with IEI-EMF symptoms. This not only provides strong support for the 
psychogenic theory of IEI-EMF, but also demonstrates that the lack of evidence for a 
relationship between symptoms and EMF exposure observed in previous studies was 
not due to the methodological concerns raised by some researchers and IEI-EMF 
sufferers.  
5.1.3  Nocebo responses may reflect a normal human response and may be 
exacerbated by alarmist media coverage 
As Study 2 provided further evidence to support the psychogenic theory of IEI-EMF, it 
became crucial to understand whether the nocebo response exhibited by IEI-EMF 
sufferers is a ‘normal’ human response, and to determine the factors which may 
contribute to such a response. If healthy participants were found to exhibit a similar 
response to those who suffer from IEI-EMF during a perceived threatening exposure to 
EMF, then this may remove the stigma attached to the notion that the condition is a 
psychological illness and may help to overcome the current reluctance of IEI-EMF 
sufferers to seek psychological treatment. In addition, although there has been 
consistent evidence that both precautionary and mainstream media messages about the 
potential harmful effects of EMF exposure can negatively influence people’s beliefs and 
raise concerns about EMF exposure (Barnett, Timotijevic, Shepherd, & Senior, 2007; 
Nielsen et al., 2010; Wiedemann, Boerner, & Repacholi, 2014; Wiedemann et al., 2013; 




Witthöft et al., 2017), it has been relatively unclear whether these negative beliefs 
directly result in greater symptom formation and detection following a perceived 
exposure to EMF. This is because previous research has either not assessed the effect of 
explicit suggestions of risk from EMF exposure (which may induce negative 
expectations) (Szemerszky, Köteles, Lihi, & Bárdos, 2010), has assessed somatosensory 
perception and not symptom perception (Bräscher, Raymaekers, Van den Bergh, & 
Witthöft, 2017), or has not included a verified non-exposure condition, which may have 
resulted in insufficient statistical power to detect effects in non-anxious healthy 
participants (Witthöft & Rubin, 2013). Thus, it has remained unclear as to whether the 
negative beliefs induced by explicit suggestions about EMF exposure contribute to a 
symptomatic nocebo response. 
To address these issues, Study 3 (Chapter 4, Verrender, Loughran, Dalecki, 
Freudenstein, & Croft, 2018) tested whether perceived EMF exposure could elicit 
symptoms in a healthy population sample, and whether viewing an alarmist video 
emphasising the ‘adverse effects of EMF exposure’ could exacerbate a nocebo response 
in a healthy population. In this study, participants were first randomly assigned to view 
either an alarmist video, which emphasised the ‘adverse effects of EMF exposure’, or a 
control video completely unrelated to EMF health effects, before completing a series of 
2 open-label (RF-ON and RF-OFF) and 12 randomised, double-blind, counterbalanced 
provocation trials (6 RF-ON, 6 Sham). Importantly, like Study 2, the open-label trials 
were used to verify that the experiment contained both active and sham exposure 
conditions. By demonstrating that the experiment contained a ‘no exposure’ condition, 
Study 3 was able to more-clearly determine whether any observed increases in 




In line with Study 2, the results of Study 3 showed that healthy participants reported 
higher symptom scores in the RF-ON compared to the RF-OFF open-label trial. 
However, in the subsequent double-blind trials, no difference in either belief of 
exposure or symptoms was found between the RF-ON and sham conditions. Belief of 
exposure was also found to be positively associated with higher symptom scores in the 
double-blind trials, giving further indication that a nocebo effect, rather than EMF 
exposure itself, was responsible for the increase in symptoms. These results again 
demonstrate that knowledge and/or awareness of the exposure condition is essential for 
producing an effect. The large effect sizes observed for the relationship between belief 
of exposure and symptoms in the open-label trials of Study 2 (ES = 3.6) and Study 3 
(ES = .71) also provide robust support for the notion that a nocebo effect can explain 
symptoms attributed to EMF exposure, and suggest that the nocebo response exhibited 
by IEI-EMF sufferers may be a normal human response. Participants who viewed the 
alarmist media video were also found to report higher symptom scores in the open-label 
trials; and a greater increase in state anxiety and risk perception from baseline, than 
those who viewed the control video. This indicates that viewing sensationalist media 
reports about perceived environmental hazards both raises concerns and negative beliefs 
about EMF exposure, and may also contribute to a symptomatic nocebo response. 
While these findings provide further support for the psychogenic theory of IEI-EMF, 
they are also consistent with a large amount of evidence which has demonstrated that 
health warnings can increase concerns about environmental exposures and elicit 
symptomatic nocebo responses (Crichton, Chapman, Cundy, & Petrie, 2014). For 
instance, Winters et al. (2003) found that participants who had received warnings about 




physiologically irrelevant) odour stimulus than participants who had received no prior 
information about environmental pollution. Similarly, Crichton, Dodd, Schmid, 
Gamble, and Petrie (2014) demonstrated that healthy participants who had received 
information about an expected negative physiological effect of wind turbine infrasound 
reported symptoms that aligned with that information during exposure to both active 
and sham infrasound. In a follow up study, Crichton and Petrie (2015a) found that the 
framing of information is important in eliciting an effect. In that study, positively 
framed health information about the effects of infrasound exposure was shown to 
reverse an initial symptomatic nocebo response that was generated by negatively framed 
information. Clearly, the type of information disseminated in public has profound 
effects on expectations and the experience of nocebo responses. In a powerful 
demonstration of the role of expectations in producing symptoms, Landgrebe et al. 
(2008) deceived IEI-EMF participants into thinking that they were being exposed to 
EMF. The results showed that the deception not only lead to expectations which 
resulted in symptom formation, but was also accompanied by activations of the brain 
regions known to be involved in pain perception. This not only demonstrates the role of 
expectations in producing a nocebo response, but also provides a psycho-
physiologically plausible mechanism as to why symptoms develop and are detected 
during nocebo responses. Given the strong indications of the determinative role of 
nocebo effects and negative expectations in eliciting symptoms attributed to EMF, it is 
possible that the consistent misrepresentation of the scientific evidence in the 
mainstream media (Claassen, Smid, Woudenberg, & Timmermans, 2012; Eldridge-




5.1.4  Implications for developing effective treatments and interventions for 
IEI-EMF sufferers 
Given the historical lack of evidence for an association between exposure to low level 
EMF and adverse health effects, the development of effective treatments for people who 
experience IEI-EMF has remained relatively challenging. While many public health 
organisations and governments have recommended exposure reduction strategies to 
those who are concerned about their EMF exposure, the current evidence does not 
provide any support to the notion that such strategies are effective for treating IEI-EMF. 
The difficulty in developing treatments and interventions for those who experience IEI-
EMF has also been limited by sufferers’ firm belief that the condition is caused by 
exposure to EMF and the stigma attached to the notion that the condition is 
psychological in origin, with the suggestion that symptoms are more closely related to a 
psychosomatic phenomenon often attracting derision from IEI-EMF advocacy groups. 
Overall, the results of the present thesis have provided strong support for the 
psychogenic theory of IEI-EMF, which has several implications for the development of 
effective treatments and support for IEI-EMF sufferers.  
For example, exposure reduction strategies are one of the most commonly adopted 
interventions employed by IEI-EMF sufferers. Generally, exposure reduction strategies 
involve minimising or avoiding the use of EMF emitting technologies. However, many 
exposure reduction strategies involve considerable social and/or financial cost without 
any tangible benefit. For instance, although rooms and buildings can be shielded from 
EMF through the use of metallic paints or the construction of Faraday cages, these 
methods are often extremely expensive, and vary greatly in their ability to attenuate RF-




reduce EMF exposure from personal devices, such as protective stickers for personal 
devices or protective clothing fabrics, are often ineffectual or have not been supported 
by empirical tests of their claims (Leitgeb, Cech, Schröttner, & Kerbl, 2008; Rubin, Das 
Munshi, & Wessely, 2006). In a recent survey study, Hagström, Auranen, and Ekman 
(2013) found that 76% of IEI-EMF respondents reported the reduction or avoidance of 
EMF as an action they had taken to manage their condition and that this behaviour 
helped in their full or partial recovery. Yet, as the current thesis has found no support 
for the toxicogenic explanation of IEI-EMF, exposure reduction strategies are likely to 
be ineffective, and may only provide a limited placebo-like solution that would only be 
useful in specific and limiting circumstances, such as in an IEI-EMF sufferers’ home. 
Moreover, electromagnetic sanitation through exposure reduction or avoidance 
behaviour may be counterproductive, as it may reinforce an IEI-EMF sufferers’ belief 
that their symptoms are caused by EMF and worsen their condition when they perceive 
that they are in an environment with EMF (Rubin et al., 2006). In addition to exposure 
reduction, complementary and alternative medicine treatments are also popular amongst 
people who suffer from IEI-EMF (Huss & Röösli, 2006). Such treatments, however, 
have rarely been evaluated in controlled studies with IEI-EMF participants, and thus 
their effectiveness in treating the condition remains to be determined. Of the few studies 
that have assessed the use of acupuncture in treating patients with ‘environmental 
illnesses’ (Arnetz, Berg, Anderzen, Lundeberg, & Haker, 1995) and antioxidant vitamin 
supplements to treat individuals with IEI-EMF (Hillert, Kolmodin-Hedman, Eneroth, & 
Arnetz, 2011), no specific therapeutic benefits were found. 
In an attempt to find an explanation and solution for their symptoms, many IEI-EMF 




professionals. Although data concerning the use of health services by IEI-EMF sufferers 
in Australia is lacking, survey studies evaluating the use of GP consultations in 
European nations have shown that the majority of GPs in these countries have been 
consulted at least once by IEI-EMF sufferers (Huss & Röösli, 2006; Kowall, 
Breckenkamp, Heyer, & Berg-Beckhoff, 2010; Leitgeb, Schröttner, & Böhm, 2005; 
Slottje et al., 2017). For instance, Leitgeb et al. (2005) reported that at least two thirds 
of GPs who responded to the survey were frequently consulted by IEI-EMF sufferers in 
Austria, while Huss and Röösli (2006) found that 69% of respondent GPs reported 
having at least one consultation about symptoms attributed to EMF. Alarmingly, many 
of these survey studies have revealed that health professionals generally have a poor 
understanding of the current scientific consensus regarding EMF exposure and health 
risks and that many consider a causal relationship between EMF and health complaints 
to be at least to some degree plausible. For example, Leitgeb et al. (2005) found that 
96% of GP respondents either ‘totally’ or ‘to some degree’ believed in the health 
relevant role of EMF exposure in producing symptoms or illness. Similarly, Huss and 
Röösli (2006) found that respondent GPs judged the relationship between EMF 
exposure and symptoms to be plausible in 54% of cases. Although it is concerning that 
health professionals may be fostering people’s beliefs that EMF exposure is the cause of 
their symptoms, this may be due to the GPs own insufficient knowledge, or a limited 
understanding of the scientific evidence. For instance, Leitgeb et al. (2005) reported that 
only 25% of medical practitioners had consulted the scientific literature for information 
about the potential health risks of EMF, while only 4% reported receiving information 
from health agencies or governments. In addition to this, it is also possible that GPs 
have evaluated the relationship between EMF exposure and symptoms to be plausible 




patients in an area which they themselves perceive to be scientifically uncertain. 
Nevertheless, given that the studies presented in the current thesis provide no support 
for the role of EMF in producing symptoms, and given the apparent contradiction 
between physicians’ opinions and the positions of the researchers and the world’s 
leading health authorities on EMF health risks, it is clear that greater effort is needed to 
communicate the current position of science to these first-line health professionals so 
that they can begin to discuss this issue and develop appropriate alternative 
interventions with their patients (Slottje et al., 2017).  
Helping patients to consider alternative explanations for their symptoms has been found 
to be effective across a range of similar conditions that are characterised by the 
presentation of non-specific symptoms without identifiable cause, such as chronic 
fatigue syndrome (van Hout, Wekking, Berg, & Deelman, 2003). Yet, the stigma 
attached to the notion that IEI-EMF is more closely related to a psychological illness 
has proven to be a difficult challenge to overcome, and simply telling IEI-EMF 
sufferers that their symptoms do not have a toxicological cause is not an effective way 
to alleviate symptoms (Rief, Heitmüller, Reisberg, & Rüddel, 2006). For example, 
Nieto-Hernandez, Rubin, Cleare, Weinman, and Wessely (2008) found that providing 
feedback to IEI-EMF sufferers about their lack of ability to discriminate between active 
and sham exposures had no influence on subsequent symptom levels or perceived 
sensitivity to EMF. Likewise, van Moorselaar et al. (2017) found that while feedback on 
provocation study results reduced IEI-EMF sufferers’ certainty about their ability to 
respond to acute exposure scenarios, the overall feedback did not materially change 
their perceptions of being sensitive to EMF. As Study 2 and Study 3 have demonstrated 




EMF, interventions which focus on these psychological processes, such as Cognitive 
Behavioural Therapy (CBT), may offer an alternative avenue for treatment research and 
development. 
CBT is a form of structured psychotherapy designed to change unhelpful or unhealthy 
thoughts and behaviours (Neenan & Dryden, 2014). It is a problem-focused and 
individualised approach that focuses on remedying immediate problems, but it also 
attempts to develop long-term strategies to replace thoughts and behaviours that 
interfere with a person’s happiness and satisfaction with their life (Neenan & Dryden, 
2014). CBT has been found to be an effective treatment for a range of psychological 
issues, such as depression and anxiety, and it has also been used extensively to reduce 
somatic symptoms in somatosensory disorders and to reduce the side-effects of 
medications (e.g. nausea associated with chemotherapy for the treatment of cancer) 
(Neenan & Dryden, 2014). Given that CBT has also been shown to be efficacious in 
treating other conditions characterised by medically unexplained symptoms (Edwards, 
Stern, Clarke, Ivbijaro, & Kasney, 2010; Escobar et al., 2007; Sharpe et al., 1996; 
Speckens et al., 1995), it may also be an appropriate approach for treating IEI-EMF. 
However, as only a limited number of studies have assessed the efficacy of CBT as an 
intervention for IEI-EMF sufferers, the potential benefits of this treatment option 
remain to be adequately clarified. 
To date, only four studies have assessed the efficacy of CBT as an intervention for 
suffering from IEI-EMF. After assessing symptoms and quality of life outcomes in IEI-
EMF sufferers following CBT, three of these studies found reductions in self-ratings of 
hypersensitivity (Hillert, Arnetz, Hedman, & Dölling, 1998), disability (Andersson et 




and degree of suffering (Harlacher, 1998), while one study did not report any 
significantly better outcomes than the control condition (Hillert, Savlin, Levy Berg, 
Heidenberg, & Kolmodin-Hedman, 2002). However, while the majority of these studies 
generally indicate that CBT may be an effective treatment for those who suffer from 
IEI-EMF, a number of possible methodological issues have limited our understanding 
of the long term efficacy of CBT as an IEI-EMF treatment (Rubin et al., 2006). For 
example, no studies have conducted follow-up assessments of patients for more than 6 
months, so it is unclear how long any beneficial effects of CBT last in these cases 
(Rubin et al., 2006). Furthermore, it is possible that the beneficial effects reported in 
these studies were actually associated with the general non-specific effects of receiving 
psychotherapy (Rubin et al., 2006). Although this could be interpreted as a useful 
placebo-like effect, and would not be an issue while therapy is ongoing, it is unclear if 
or for how long these benefits would continue post-therapy. Future studies, therefore, 
could usefully clarify the effectiveness of CBT as an intervention for people suffering 
from IEI-EMF by employing longer-term follow-up assessments. 
While CBT may prove to be an effective treatment for IEI-EMF sufferers, the results of 
Study 2 and Study 3 also indicate that other psychological interventions, which focus on 
the underlying factors which drive nocebo responses, may provide another alternative 
avenue for treatment research and development. Generally, a nocebo response occurs 
when conscious or subconscious negative expectations trigger or exacerbate adverse 
symptoms in response to an exposure that is not known to cause those effects (Bräscher, 
Kleinböhl, Hölzl, & Becker, 2017; Hahn, 1997). These expectations may be induced by 
explicit suggestions about the potential effects of an exposure (Benedetti, Lanotte, 




classical conditioning (Bräscher, Kleinböhl, et al., 2017). Consequently, interventions 
which focus on modifying conscious or subconscious negative expectations may 
provide an effective means for treating people who suffer from IEI-EMF.  
For instance, there is some emerging evidence that providing a scientific explanation of 
the nocebo response and its mechanisms following a provocation trial may offer an 
effective way to change people’s conscious expectations about their IEI symptoms. 
Recently, Crichton and Petrie (2015b) found that participants who reported symptoms 
during infrasound exposure returned mood and symptom levels to baseline levels in a 
subsequent exposure after they had received an explanation of the nocebo response with 
supporting scientific evidence. This suggests that providing an explanation of the 
nocebo response was able to modify people’s response during a subsequent provocation 
trial. Given the results of Study 3, it may also be possible that explaining that the 
nocebo response experienced by IEI-EMF sufferers is a normal human response (rather 
than an abnormal psychological disorder) may also help in modifying conscious 
expectations; however, further investigation is required to determine the efficacy of 
such an intervention with IEI-EMF participants. If, however, classical conditioning is 
one of the main factors driving a nocebo response (as suggested by some theorists, for 
example, Barsky, Saintfort, Rogers, & Borus, 2002; Webster et al., 2016), then 
interventions based on systematic desensitization, in which repeated exposure to EMF is 
paired with relaxation techniques, may also diminish a possible conditioned response to 
environmental stimuli (Rubin et al., 2006). The efficacy of such an intervention with 
IEI-EMF patients, however, remains to be empirically tested, and it is unclear whether 




associated with a broad range of EMF sources compared to those who only experience 
symptoms associated with specific devices.  
The way health information is framed may also modify conscious or subconscious 
expectations about environmental exposures. For example, there is evidence that has 
shown that framing health information about environmental exposures in a neutral or 
benign way can ameliorate IEI symptoms. Crichton and Petrie (2015a) found that 
participants who formed negative expectations from media warnings about infrasound 
from wind turbines reported increased symptoms and deterioration in mood during 
simultaneous exposure to infrasound and audible wind farm noise, yet those who 
formed positive expectations derived from information about the therapeutic effects of 
infrasound experienced improvements in symptoms and mood. This demonstrates the 
malleability of symptomatic responses, and highlights the important role of message 
framing on expectations and placebo/nocebo effects. Yet, while these studies indicate 
that interventions which focus on modifying conscious or subconscious expectations 
can effectively reduce symptoms associated with other IEI conditions, as no similar 
studies have been conducted with people who report experiencing IEI-EMF, it remains 
unclear as to whether such effects could be replicated in IEI-EMF sufferers.  
5.2  Potential Limitations 
Although considerable effort was made to address the limitations of previous research 
in each of the studies contained within the present thesis, a number of possible issues 
need to be taken into consideration when interpreting the results of the present thesis. 
Many of these issues relate to potential limitations associated with the ecological 
validity of human provocation studies and the methods used to assess IEI-EMF 




The first potential limitation relates to exposure duration. While the majority of people 
with IEI-EMF report that their symptoms typically occur within minutes to hours after 
exposure, some report that their symptoms are the result of longer exposures or of an 
accumulation of exposures over time (Hocking, 1998; Röösli, Moser, Baldinini, Meier, 
& Braun-Fahrländer, 2004). Generally, to make them feasible, provocation studies are 
limited to using short term, acute exposures. As the exposure intervals implemented in 
the studies contained in the present thesis were limited to 30 minutes or less, the 
conclusions drawn from these studies cannot be used to comment on possible long term, 
chronic effects of EMF exposure. However, while the more chronic forms of IEI-EMF 
remain under-investigated using the provocation study paradigm, it is important to note 
that there has been no convincing evidence from epidemiological studies that long term 
exposures have an adverse effect on human health either (Röösli et al., 2010). Although 
many advocates of the toxicogenic theory of IEI-EMF argue that the condition may be a 
result of a ‘build up’ of chronic exposures over time (for e.g. over several 
days/weeks/months), this could only be determined empirically using a sufficient 
amount of active and sham exposure conditions (as per the methodology of Study 2). 
While the amount of time it would take to conduct such provocation trials would make 
this extremely difficult (and likely not feasible), given the complexities of subjectively 
trying to summate average exposure periods over long intervals with a multitude of 
potential confounding factors (in daily life), it seems unreasonable that IEI-EMF 
sufferers could reliably claim that their symptoms were the result of chronic exposures 
to EMF. Therefore, acute exposure trials not only offer the most feasible way of testing 
the claims of IEI-EMF sufferers, they also offer the most direct means of testing the 




The use of simulated exposure signals may be another possible limitation. As no 
consistent pattern in the types of EMF emitting sources that are claimed to trigger IEI-
EMF symptoms has been identified, provocation studies have generally relied on 
exposure systems which simulate the emissions produced by everyday devices. The 
studies contained in the present thesis used exposure systems which either simulated 
mobile handset-like exposure (Study 1) or generated a signal which was digitally 
modulated in similar manner to signals from Wi-Fi routers and 3G/4G mobile phones 
(Study 2 and Study 3). While it is often argued that simulated exposure signals can be 
used to reliably test whether a well-characterised exposure is associated with an adverse 
effect (Boutry et al., 2008; Regel & Achermann, 2011), some researchers have criticised 
the use of simulated exposure signals and argue that experimental findings could only 
be ecologically valid if relevant commercially available EMF emitting devices were 
used (Panagopoulos, Johansson, & Carlo, 2015). Unlike everyday devices (such as 
commercially available mobile phones), which produce a relatively localised yet 
variable SAR distribution which can be reduced by orders of magnitude with greater 
separation from the exposure (Loughran, McKenzie, Anderson, McIntosh, & Croft, 
2008), simulated exposure devices produce controlled and precise exposures. Although 
it may be possible that the unpredictable and heterogeneous nature of everyday EMF 
emissions is an important factor for eliciting an adverse effect (Oftedal, Straume, 
Johnsson, & Stovner, 2007; Rubin et al., 2010), it is important to note that there is 
currently no evidence to support this notion. Despite this, it may be advantageous for 
studies to use simulated exposures if they are attempting to develop an understanding of 
whether exposures with a specified dosimetric value can affect health (Loughran et al., 
2008). For instance, in Study 1, a planar exposure system was used to generate a mobile 




performance in a dose dependent manner. Because the SAR distribution produced by 
the exposure system was more homogenous than that produced by a typical mobile 
phone, the findings cannot be used to definitively comment on whether cognitive 
performance is influenced by exposure to EMF emitted by mobile phones, but rather 
can only reflect whether RF-related bioeffects occur at the maximum exposure level 
within the exposed hemisphere. However, in respect to the endpoints of the present 
thesis, the use of a planar exposure system in Study 1 was appropriate, as exposure of 
the whole hemisphere maximised the chance of finding any possible effects on 
cognitive performance. Similarly, while the portable exposure device used in Study 2 
and Study 3 generated a signal that would not typically be emitted by everyday devices 
(as the signal band was reserved for industrial, scientific and medical use), initial non-
blinded open-label trials were used to verify that participants believed that they were 
being exposed and that they responded to the signal, which verified that it was 
appropriate for the purposes of the study.  
Some IEI-EMF advocates also view the use of subjective measures of symptoms as a 
major limitation of provocation studies, and argue that such measures are unreliable and 
insufficient to either prove or disprove the existence of a causal link between the 
reported symptoms and EMF (Leszcynski, 2018). While both Study 2 and Study 3 used 
questionnaires to assess participant’s subjective symptom experiences, it is important to 
note that such questionnaires are designed to specifically test the claims of IEI-EMF 
sufferers, and that no objective test for symptom experiences has been developed and no 
formal diagnostic tests have been established to identify people who experience IEI-
EMF. Although Leszcynski (2018) argues that physiology based research examining 




individual sensitivity to EMF, it first needs to be established that the exposures claimed 
to elicit a symptom response are actually capable of eliciting a symptom response. As 
no toxicogenic relationship between adverse health effects and exposure to EMF has 
been established, and due to the extremely heterogeneous nature of IEI-EMF, there is no 
reason to expect that empirical tests assessing whether one of a vast number of 
physiological endpoints is influenced by EMF exposure would contribute to our 
understanding of the condition. In this sense, only double-blind provocation studies with 
appropriate verification procedures (as implemented in Study 2) are able to test the 
symptom claims of IEI-EMF sufferers.  
In addition to the aforementioned issues, a number of other possible limitations apply to 
the specific studies contained within this thesis. First, the statistical analyses in Study 1 
controlled for comparison-wise error by restricting the planned contrasts to degrees of 
freedom error without multiple comparison adjustment (Tabachnick & Fidell, 2013). 
However, this method does not control for experiment-wise error, and so it is still 
possible that the results of Study 1 were influenced by Type 1 error. Second, despite 
using an improved methodology, the results of Study 2 cannot be generalised across the 
entire IEI-EMF population, given the relatively small number of participants who 
completed the study. Recruitment of sufficient numbers of participants is one of the 
most challenging aspects of conducting provocation studies involving IEI-EMF 
participants, as reflected by the relatively small sample sizes of previous studies 
(median number of IEI-EMF participants in previous studies = 19) (Rubin et al., 2010). 
However, given the consistency within the literature, it is unlikely that the low sample 
sizes are the reason for the overall failure of provocation studies to detect a toxicogenic 




after pooling the results from five separate provocation studies, Roosli (2008) still failed 
to detect a significant effect of exposure. The reluctance to participate in provocation 
studies may be due to scepticism of the scientific process, concerns about the possible 
adverse effects caused by voluntary exposure, and/or of distrust of the research group 
conducting the investigation. Nevertheless, the considerable methodological 
improvements employed in Study 2 meant that it was appropriately designed to detect 
partial IEI-EMF responses within each case separately. Finally, it is possible that pre-
existing beliefs about the relative harmfulness of EMF exposure may have influenced 
the results of Study 3 via a ceiling effect. While it is impossible to control for the beliefs 
formed by situational factors (such as viewing a particular media report before an 
experimental session), pre-screening could be used to allocate participants into “high” 
and “low” risk perception groups before any experimental manipulation has taken place, 
which would allow this issue to be controlled for experimentally in future study designs.  
5.3  Future Directions 
Given that a considerable amount of research has determined that IEI-EMF is of a 
psychogenic origin, it is important that future research is directed towards targeting the 
factors that contribute to nocebo responses. This needs to be a multifaceted approach, 
which involves not only the communication of the current scientific evidence to 
frontline medical professionals, but also the dissemination of accurate information to 
the community more broadly. As the present thesis found that the nocebo effect was 
exacerbated by alarmist media emphasising the ‘adverse effects of EMF’ in healthy 
participants, it is regrettable that some commentators and advocates of the toxicogenic 
theory continue to discuss IEI-EMF without sufficient evaluation of the literature (e.g. 




effects in society more broadly. Evidently, the scientific community need to develop 
effective ways to communicate the current state of science (Rubin et al., 2011). 
Moreover, further research is needed to clarify how personality traits may interact with 
situational factors (such as viewing a particular media report) to influence peoples 
worries and expectations regarding EMF exposure in order to identify people who may 
be more susceptible to alarmist media reports and resultant nocebo effects. 
In addition to this, future research could benefit by focusing on developing effective 
interventions and support for those who suffer from IEI-EMF. This could be achieved 
by first clarifying the efficacy of psychological approaches to treating IEI-EMF (Rubin 
et al., 2006), irrespective of whether these are CBT or non-CBT based interventions. 
While some evidence has shown that CBT may be an effective strategy for treating IEI-
EMF (Andersson et al., 1996; Harlacher, 1998; Hillert et al., 1998), non-CBT related 
interventions may also provide a useful direction for future research. In particular, given 
that Crichton and Petrie (2015a) found that positively framed health information may 
reverse or dilute the effect of negative expectations formed by alarmist media in the 
context of infrasound exposure, future studies could profit from exploring whether 
positively framed messages about EMF exposure can ameliorate symptoms triggered by 
negative expectations. However, as many who experience IEI-EMF firmly believe that 
EMF is the cause of their symptoms, caution should be applied when providing 
psychological interventions or explanations, as such strategies may be interpreted as 
being offensive or lacking credibility. Thus, alongside studies assessing the efficacy of 
psychological approaches to treating IEI-EMF, it would be important for future research 
to focus on developing effective communication of the research between scientists, 




5.4  Conclusions 
Overall, the studies presented in this thesis have found no support for the view that 
toxicogenic processes can explain symptoms attributed to EMF exposure. Instead, the 
results of the present thesis strongly indicate that psychological factors play an 
important role in triggering, maintaining, or exacerbating symptoms in response to 
perceived exposure to EMF.  
In particular, while the present research found that exposure to mobile phone-like RF-
EMF may improve cognitive performance on a working memory task, the slight 
improvement in performance observed in Study 1 did not provide convincing evidence 
that exposure to mobile phone-like RF-EMF can influence cognitive performance in a 
dose dependent manner, let alone adversely (Chapter 2, Verrender, Loughran, Dalecki, 
McKenzie, & Croft, 2016). This result is significant because it provides further support 
to the overall evidence that while exposure to RF-EMF within the established exposure 
guidelines (ICNIRP, 1998) can trigger subtle biological and physiological effects (as 
has been reported previously in relation to the EEG), these changes do not necessarily 
constitute an adverse effect on health or functioning. Given this finding, Study 1 also 
did not identify any sensitive cognitive performance endpoints with which to test IEI-
EMF participants. The present doctoral research also demonstrated  that awareness and 
belief of exposure, rather than EMF exposure itself, is crucial in eliciting symptoms 
attributed to EMF (Chapter 3, Verrender, Loughran, Anderson, et al., 2018; Chapter 4, 
Verrender, Loughran, Dalecki, Freudenstein, & Croft, 2018). While this not only 
provides further support for the psychogenic theory of IEI-EMF, the fact that healthy 
participants were found to exhibit a similar symptomatic nocebo response to IEI-EMF 




4, Verrender, Loughran, Dalecki, Freudenstein, & Croft, 2018). This has important 
implications for developing effective treatments for IEI-EMF sufferers, and may help to 
remove the stigma attached to the notion that IEI-EMF is a psychological issue. Finally, 
this research also showed  that viewing an alarmist media report that emphasised the 
‘adverse effects of EMF exposure’, increases anxiety and concerns about EMF exposure 
and may also exacerbate nocebo responses in otherwise healthy people (Chapter 4, 
Verrender, Loughran, Dalecki, Freudenstein, & Croft, 2018). This demonstrates the 
clear role of negative expectations in eliciting symptomatic nocebo responses and 
highlights the need for the dissemination of information which accurately reflects the 
current state of science.  
The research presented in this doctoral thesis has considerable implications for the 
development of effective treatments and support for those who suffer from IEI-EMF. 
First, it suggests that it is important for interventions to focus on helping IEI-EMF 
sufferers to consider alternative explanations for their symptoms, and second, that 
interventions attempt to modify the negative expectations which contribute to 
symptomatic nocebo responses. In addition to this, given that explicit suggestions, 
negative expectations and nocebo responses have been found to play a determinative 
role in eliciting symptoms attributed to EMF exposure, the evidence presented in this 
thesis clearly indicates that greater effort is needed to communicate the current state of 
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